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Breast interventional devices: how they evolve and
define new subspecialities
F Burbank
Laguna Niguel, California, USA
Breast Cancer Research 2006, 8(Suppl 1):P1 (doi: 10.1186/bcr1416)
From 1930 to 1990 annual age-adjusted breast cancer death rates for
women in the United States remained remarkably constant, oscillating
around 32 deaths per 100,000 over 60 years. During this long time-
frame, the surgical treatment of breast cancer evolved from radical
mastectomy with mandatory lymph node dissection to lumpectomy
coupled with radiation therapy. With this new paradigm, lymph node
dissection was reserved for women with tumor-invaded axillary lymph
nodes. Beginning in the 1970s, chemotherapy after surgery (adjuvant)
and before surgery (neoadjuvant) was added to surgical treatment. The
radical diminution in the scope of breast surgery did not alter the
national breast cancer death rate. Doing less surgery was neither
harmful nor beneficial to long-term survival from breast cancer.
In the 1980s two events changed this static picture: the addition of
tamoxifen to adjuvant and neoadjuvant chemotherapy, and the
introduction of mammography. Beginning in 1990 annual breast cancer
death rates in the United States began to fall, and have continued to
fall each year since then. In 2001, the last year of published statistics,
the breast cancer death rate was 26 deaths per 100,000. Best
estimates for where to credit this dramatic drop in death rate place
approximately 50% of the credit with improved adjuvant chemotherapy
and 50% with mammography.
Abnormal mammograms demand a breast biopsy since only one in five
abnormal mammograms is actually a breast cancer. Consequently,
widespread adoption of mammography has produced an image-guided
breast biopsy industry in the United States. Open, surgical breast
biopsy has been replaced with image-guided breast biopsy because
improved breast biopsy tools have made image-guided breast biopsy
equivalent in accuracy to open, surgical breast biopsy. These tools, in
turn, have changed the professional lives of surgeons, pathologists,
and mammographers, leading to the development of dedicated breast
surgeons, breast pathologists, and interventional breast radiologists.
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Evaluation of digital mammography: update on the
UK position
S Cush
NHS Cancer Screening Programmes, Sheffield, UK
Breast Cancer Research 2006, 8(Suppl 1):P2 (doi: 10.1186/bcr1417)
There is general acceptance that digital mammography screening will
eventually replace the current analogue systems. Before this
technology is introduced more widely for breast screening, however,
assurances need to be made that it can improve or at least equal, the
existing system in both quality and performance [1]. It is not simply a
matter of replacing the existing mammography sets with digital
systems. The Advisory Committee on Breast Cancer Screening
supported setting up a multiprofessional Digital Steering Group to
bring together the relevant expertise in breast screening and digital
systems. The aim of the group was to identify areas of work required to
be undertaken prior to implementation of digital systems in the
screening service. The group had representation from England, Wales,
Scotland and the private sector.
Six areas of work were identified: technical parameters, clinical para-
meters, information issues, purchasing, training, and screening on mobiles.
The Digital Steering Group of the National Health Service Breast
Screening Programme (NHSBSP) has concluded that all the direct
digital mammography systems tested by the NHSBSP meet the image
quality and dose standards in the European Guidelines for Digital
Mammography [2].
Only one of the computed radiography systems tested by the
NHSBSP meets these standards. However, testing and evaluation of
the new designs is ongoing.
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Digital mammography in the United Kingdom: the
reality
M Wallis
Warwickshire, Solihull & Coventry Breast Screening Unit, Coventry, UK
Breast Cancer Research 2006, 8(Suppl 1):P3 (doi: 10.1186/bcr1418)
This talk will discuss the outcomes from the sites currently piloting full-
field digital screening and will outline progress on the key outstanding
issues.
To date, all the equipment has been technically satisfactory and
produces good image quality at an acceptable dose. Several units have
been shown to work on mobile vans. Translating this into safe and
affordable screening has been less successful.
No full-field digital mammography machine will work at its best without
patient archiving and communications systems and a radiology
information system. Integration into the current Information Technology
structures has been hampered by parallel development and
implementation work on the national Information Technology programme
and a national reluctance to spend local money on short-term fixes.
The current differences in cost will not be offset by savings in film and
film-handling processes, so improvements in throughput (i.e. shorter
appointments and/or longer days) are required, and this has not been
fully addressed.
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DMISTifying digital mammography in the USA
C D’Orsi
Imaging Centre, Winship Cancer Institute, Atlanta, Georgia, USA
Breast Cancer Research 2006, 8(Suppl 1):P4 (doi: 10.1186/bcr1419)
Principles, technique and equipment Full field digital mammography
(FFDM) offers potential improvements over the limitations of screen film
mammography (SFM). While film acts both as the detector and display
medium for the breast, a digital technique can separate these two
functions with the possibility of maximizing the performance of each
independently.
Digital detectors create an electronic image of the structure radio-
graphed as picture elements or pixels. Detectors used are typically
amorphous silicon flat panels, charge-coupled devices (CCDs), or
amorphous selenium.
The various approaches that have been taken to develop FFDM
systems include slot scanning with indirect capture utilizing a moving
row of CCDs in order to achieve the full breast coverage, flat panel
designs with both direct or indirect image capture and photo-
stimulable phosphor plates.
Clinical FFDM Lewin and colleagues conducted the first blinded
prospective study comparing SFM to FFDM. The recall rate for FFDM
was less than SFM (P < 0.001), with fewer patients sent to biopsy but
with no significant difference in cancer detection. It thus appears from
this study that FFDM was more effective for detecting malignancy than
SFM, sending fewer women to biopsy for a similar yield of malignancy.
Two other trials were also reported on SFM and FFDM in a screening
situation. The Oslo I trial did not demonstrate a significant difference in
cancer detection and the recall rate was 4.6% for FFDM and 3.5% for
SFM. This difference was not significant. A second trial, the Oslo II
study, demonstrated that the recall rates were statistically higher for
FFDM than SFM. The ACRIN DMIST trial demonstrated a significant
difference in favor of a digital technique for women under 50, for
women with dense breasts and for premenopausal and perimeno-
pausal women.
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How are symptomatic services run in the United
Kingdom?
I Monypenny
Cardiff & Vale NHS Trust and Breast Test Wales, Cardiff, UK
Breast Cancer Research 2006, 8(Suppl 1):P5 (doi: 10.1186/bcr1420)
Breast clinics have developed in a fairly ad hoc way over the past
15 years, often led by experience from breast screening clinics. Although
the concept of multidisciplinary teams is now well established, the
interaction between members of the teams is much less well defined,
particularly as to who is responsible for managing patients through the
diagnostic pathway.
As part of the Association of Breast Surgery at BASO symptomatic
audits that have been carried out over the past 6 years, some units
have submitted data on all patients seen in their clinics, giving a
dataset of over 100,000 patients from 58 breast units (median age 45,
range 1–102). Overall 53% of patients have ultrasound and 57%
mammography, with both imaging methods used in 32%. Needle
biopsies (core or fine needle aspiration cytology) are carried out on
26% of patients, with 69% showing benign pathology. The pre-
operative cancer diagnosis rate is 91%.
This dataset has been explored to look at variation in practice across
units, and shows quite wide variation in the reported use of mammo-
graphy (26–100%), ultrasound (4–96%), and needle biopsy (6–57%),
although this does not obviously alter the cancer diagnosis rates for
individual units. These results will be presented to inform discussion on
what may be best practice.
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Symptomatic breast clinics: the radiologist’s
perspective
MJ Michell
Department of Radiology, King’s College Hospital, London, UK
Breast Cancer Research 2006, 8(Suppl 1):P6 (doi: 10.1186/bcr1421)
Breast radiology, encompassing high-quality mammography, ultra-
sound and image-guided biopsy, is central to the aims of the modern
breast clinic — to address the concerns of patients presenting with
symptoms of breast disease and to make an accurate and timely
diagnosis.
There has recently been increased pressure on clinics due to improved
public awareness of breast disease leading to earlier patient
presentation, often with subtle clinical signs. The diagnosis of breast
cancer at an earlier stage, contributing to the improved outcome for
breast cancer patients, has been accompanied by increased numbers
of women presenting to clinics with benign conditions, increasing the
workload for radiology services. Further pressure on services has come
from increasing expectations from the public who would welcome rapid
access to diagnostic clinics regardless of the nature of symptoms and
an assurance that all necessary tests would be performed during the
same session. Some services have had difficulty with meeting the
challenge of both maintaining accuracy and quality at the same time as
increasing capacity to meet Health Service waiting time targets.
In this presentation, different models of care for breast clinics will be
presented with data from the 2006 UK Breast Clinic Survey, and
methods for ensuring the most effective and efficient use of radiology
resources will be discussed.
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The ‘ideal’ symptomatic breast clinic
M Kissin
Mount Alvernia Hospital, Guildford, Surrey, UK
Breast Cancer Research 2006, 8(Suppl 1):P7 (doi: 10.1186/bcr1422)
Abstract not submitted.
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Dominance and nondominance of the radial scar/
complex sclerosing lesion and associated pathology
D Birchley, JR Steel, PA Jones, CS Holgate, RM Watkins
Derriford Hospital, Plymouth, UK
Breast Cancer Research 2006, 8(Suppl 1):P8 (doi: 10.1186/bcr1423)
Aim  To establish whether there is a significant difference in the
pathology associated with radial scars (RS) or complex sclerosing
lesions (CSL).
Patients and methods RS or CSL were recorded in 178 specimens
over a 17-year period. Three associated pathologies were noted —
atypical hyperplasia, in situ malignancy and invasive carcinoma. The
sclerosing lesions were categorised as to whether the RS/CSL was
dominant (i.e. larger than the associated pathology) or nondominant
(smaller than the associated pathology).
Results  Sixty-four patients (36%) had RS/CSL with associated
pathology: atypical hyperplasia (17), in situ (24) or invasive (23)
malignancy. There was a significant (P < 0.001, chi-square 17.5)
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Table 1 (abstract 8)
RS/CSL dominant
Yes No Total
Associated pathology
ADH/ALH 17 0 17
In situ 15 9 24
Invasive 7 16 23
Total 39 25 64difference in proportions for histological types between lesions where
the RS/CSL was dominant and lesions where they were not. Lesions
with a dominant RS/CSL were associated with significantly more in
situ malignancy and atypical hyperplasia. Invasive carcinoma was
associated with nondominant RS/CSL.
Conclusion  The nature of the associated pathology appears to be
related to the dominance or nondominance of the RS/CSL.
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Audit of wide bore needle biopsies graded B3: does
the final pathology justify the increasing rate of
benign biopsy?
NR Wakeham, K Satchithananda, NK Barrett
Charing Cross Hospital, London, UK
Breast Cancer Research 2006, 8(Suppl 1):P9 (doi: 10.1186/bcr1424)
A recent national audit of the West of London Breast Screening Service
showed an increased rate of benign biopsy. This may be related to the
increasing rate of wide bore needle (WBN) biopsies graded as B3
(indeterminate). Common B3 pathologies include atypical ductal
hyperplasia (ADH), columnar cell change with hyperplasia or atypia
(CCC) and intraduct papilloma (IP). Previous studies have shown an
association of these lesions with malignancy [1,2]. Our practise is to
recommend excision biopsy of these B3 lesions.
We retrospectively audited surgical excision biopsies of B3 lesions
between April 2004 and April 2005, recording mammogram findings,
patient demographics, WBN and surgical excision pathological
diagnoses.
Twenty-five women age 50–70 (mean age 58) had excision biopsy of
their B3 lesions; 64% were microcalcifications, 28% masses and the
remainder distortions.
The 14G core biopsy pathology included 38% ADH, 16% atypical
lobular hyperplasia, 16% CCC and 12% IP.
The surgical excision pathology available in 14 of these women
showed ductal carcinoma in situ in seven and invasive ductal
carcinoma in situ in three, justifying our practise. We discuss how the
surgical pathology correlates with that of the WBN.
References
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Is the Mammotome excision of indeterminate
impalpable lesions found incidentally on
mammography best practice?
S Lawson, A Hubbard
Humberside Breast Screening Service, Cottingham, UK
Breast Cancer Research 2006, 8(Suppl 1):P10 (doi: 10.1186/bcr1425)
Mammotome excision of indeterminate (B3) impalpable lesions
combined with annual mammographic follow-up can be regarded as
routine practice.
This quantitative study retrospectively reviewed consecutive
Mammotome procedures from January 2003 to July 2005. B3
outcomes were analysed by category combined with follow-up for any
evidence of histological upgrade to carcinoma.
Out of a total of 120 consecutive Mammotome procedures, 61 (58%)
had a B3 outcome. The B3 category subdivided into: 37% (n = 23)
atypical ductal hyperplasia, 37% (n = 23) as radial scars, with the
remaining 26% (n = 15) in a mixed category containing mucoceles,
lobular carcinoma in situ, and papillomata. A total of 42.6% (n = 26) of
the B3 category underwent annual mammographic follow-up with no
signs of recurrence, 41% (n = 25) proceeded to 3-yearly NHSBSP
routine recall follow-up, and 9.8% (n = 6) proceeded to surgical follow-
up with two patients being up-graded to carcinoma. Four patients were
lost to follow-up. The incidence of carcinoma in the B3 category
ranged between 3.6% and 6.3%.
Trends demonstrated that Mammotome excision for B3 lesions
combined with annual mammographic follow-up can be safe practice
providing each case is discussed within a multidisciplinary setting with
regard to atypia, past history and concordance of imaging and results.
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Radiological predictors of successful therapeutic
wide local excision of ductal carcinoma in situ:
findings from the Sloane project
A Evans1, K Clements2, A Maxwell3, H Dobson4, M Wallis5,
G Lawrence2, H Bishop3
1Nottingham Breast Institute, Nottingham, UK; 2West Midlands Cancer
Intelligence Unit, Birmingham, UK; 3Royal Bolton Hospital, Bolton, UK;
4West of Scotland Breast Screening Programme, Glasgow, UK;
5Coventry & Warwickshire Hospital, Coventry, UK
Breast Cancer Research 2006, 8(Suppl 1):P11 (doi: 10.1186/bcr1426)
The aim of this analysis was to ascertain whether mammographic
unidimensional measurement (UDM), bidimensional product (BDP)
measurement and pathological grade are helpful in predicting which
patients could be offered a successful single therapeutic wide local
excision (WLE) for ductal carcinoma in situ (DCIS).
The study group was 505 patients with DCIS whose mammograms
showed calcification, and in whom a nonoperative diagnosis had been
obtained and a WLE attempted. Mammographic calcifications were
measured in two planes at 90° on the oblique view and were classified
pathologically as high, low or intermediate nuclear grade. In the sample,
342 patients had a successful first WLE and 163 patients had further
surgery.
A UDM <35 mm and a BDP <800 mm were associated with successful
excision at first operation (69% vs 54%, P = 0.02 and 70% vs 27%,
P = 0.0001, respectively). If the BBP cut-off had been applied to these
cases, 16 unsuccessful WLEs would have been prevented but six
successful WLEs may have been replaced by mastectomies. The
histological nuclear grade did not influence the chance of a successful
first WLE (66%, 69% and 80% for low, intermediate and high nuclear
grade, respectively). The BDP maintained significance in subgroups
based on nuclear grade more frequently than UDM.
The BDP of mammographic calcification is a better predictor of
successful WLE than UDM.
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Clinical cases covering management of borderline
lesions
A Evans
Breast Institute, City Hospital, Nottingham, UK
Breast Cancer Research 2006, 8(Suppl 1):P12 (doi: 10.1186/bcr1427)
Lesions of uncertain malignant potential include radial scars, papillary
lesions and mucoceles. Lobular neoplasia and atypical ductal hyper-
plasia (ADH) are often associated with such abnormalities and present
similar problems. Columnar cell atypia and apocrine atypia, once their
natural history has been elucidated, may join this group of lesions.
The management of lesions of uncertain malignant potential has
become a more common and complex problem in recent years. The
introduction of first core biopsy and then vacuum-assisted biopsy
devices has led to an increase in the nonoperative diagnosis of such
lesions. These lesions may be incidental findings that do not represent
the clinical or radiological abnormality.
In the past, such lesions were managed by surgical excision (radial
scar, papillary lesion and ADH) or by mammographic follow-up (lobular
neoplasia). It is now recognised that the upgrade rates to ductal
carcinoma in situ or invasive cancer vary in proportion to the degree of
cellular atypia present and by the amount of tissue removed at
percutaneous biopsy. Vacuum biopsy excision is also an option for
some of these lesions.
In this session we shall discuss a number of such cases to highlight the
difficulties and dilemmas found when managing these lesions.
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Screening with digital mammography: 2-year
experiences from Vestfold County, Norway
E Vigeland, H Klaasen, TA Klingen, S Hofvind
Brystsenteret, Vestfold Hospital, Tønsberg, Norway
Breast Cancer Research 2006, 8(Suppl 1):P13 (doi: 10.1186/bcr1428)
Purpose To compare the results from high-volume screening using full-
field digital mammography (FFDM) with screen film mammography (SFM)
in the Norwegian Breast Cancer Screening Programme (NBCSP).
Materials and methods The NBCSP offers biennial two-view
mammography screening to all Norwegian women aged 50–69. As the
only county, Vestfold used FFDM during the prevalence round
(2004–2005) (Lorad Selenia; Hologic, USA). Double reading was
performed on soft-copy workstations (Sectra MX, Sweden). In total
18,369 women were screened and 142 cases of breast malignancies
were diagnosed. The results were compared with the prevalence found
in all other Norwegian counties (1996–2004), all using standard SFM.
Results  Recall rates All reasons: FFDM, 4.9%; SFM, 5.4%
(P = 0.002). Positive mammographic findings: FFDM, 4.1%; SFM,
4.2%. Technical reasons: FFDM, 0.2%; SFM, 0.6% (P  < 0.001).
Detection rates All malignancies: FFDM, 0.77%; SFM, 0.65%
(P = 0.057). Invasive tumours: FFDM, 0.55%; SFM, 0.54%. Ductal
carcinoma in situ (DCIS): FFDM, 0.22%; SFM, 0.11% (P < 0.001). No
statistically significant differences were found concerning tumour size
or involvement of axillary lymph nodes.
Conclusions  FFDM had a higher detection rate for DCIS but no
difference was observed for invasive tumours. Recall rates were lower
due to fewer technically inadequate examinations. FFDM performs well
in high-volume population-based screening.
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Symptomatic and screening film-readers: a difference
in reading style?
HJ Scott, AG Gale
Loughborough University, Loughborough, UK
Breast Cancer Research 2006, 8(Suppl 1):P14 (doi: 10.1186/bcr1429)
In the United Kingdom, screening personnel (radiologists, advanced
practitioners, breast physicians/clinicians and registrars) read breast
screening cases and symptomatic radiologists read cases that have
been referred to them. Our previous PERFORMS research has
suggested that there may be differences in reading styles between
these two groups owing to such differences in their real-life practice.
We set out to investigate whether such previously noted trends in
reading style were predictive of current performance in 2006.
Consequently, we examined the proficiency of the two groups on the
recent PERFORMS set of mammograms. The performance for a group
of 15 symptomatic readers was examined as compared with 15
screening personnel over a set of 60 difficult mammographic cases
that contained a range of features and mammographic classification
types. Both groups were matched, as far as possible, on real-life
factors that may affect reporting skill — such as case volume and real-
life reading experience. Concentrating on the groups’ specificity and
sensitivity measures identified whether current tendencies in
radiological reading style were comparable with those previously
noted. Results indicate that, on this scheme, the symptomatic readers’
tendency to ‘over-read’ comparative with screeners may still be evident.
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Promoting early breast cancer presentation in women
after their final routine breast screening mammogram
A Ramirez
Cancer Research UK London Psychosocial Group, Institute of
Psychiatry/Kings College, London, UK
Breast Cancer Research 2006, 8(Suppl 1):P15 (doi: 10.1186/bcr1430)
The London Psychosocial Group has been funded by Cancer
Research UK to develop, implement and evaluate an intervention to
encourage early help seeking among older women with breast
symptoms. It will be delivered at the point when the women leave the
routine protection afforded by the National Health Service Breast
Screening Programme. It is in line with government-recommended
practice and is complementary to the breast screening programme. The
intervention is designed to increase women’s knowledge about breast
symptoms and risk, to promote disclosure of symptoms to someone, to
reduce perceptions of barriers and to increase intentions to seek help.
The rationale and evidence base for the intervention will be presented.
We have shown that delayed presentation of breast cancer
(≥3 months) is associated with poorer survival at all ages [1]. The
intervention builds on evidence about risk factors for delayed
presentation of breast cancer [2-6] and is informed by a theoretical
framework about help-seeking for breast symptoms [7].
The ultimate aim of the intervention is to reduce the proportion of older
women with breast cancer who delay their presentation, and thereby
save lives.
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Image-guided biopsy of mammographic
microcalcifications
R Vinayagam, P Gill
University Hospital North Tees, Stockton-on-Tees, UK
Breast Cancer Research 2006, 8(Suppl 1):P16 (doi: 10.1186/bcr1431)
Aims  To audit the accuracy of radiographers taking stereotactic core
biopsies. To study whether cluster morphology influences calcium retrieval
rates. To compare radiological opinion against histological findings.
Methods and materials Retrospective analysis of all stereotactic 14G
core biopsies performed in a Breast Screening Unit over an 18-month
period (January 2004–June 2005). Usage of department database,
mammograms and case notes.
Results Of 300 biopsies, 264 were performed by radiographers. All
cases had specimen radiography. The calcium retrieval rate was 80%
in early 2004 and 95% by the end of July 2005.
The calcifications were classified into cluster, tiny cluster and scattered
cluster, according to the mammographic appearances. In the negative
biopsies they were 32%, 43% and 25%, respectively.
The comparison between the radiologist opinion against the final core
biopsy results shows 90% concordance with pathology for opinions 2
and 5, and 75% for opinions 3 and 4
Conclusion Calcium retrieval rates for radiographers initially matched,
then exceeded, those for radiologists. They also showed a steady
improvement during the study period, rising to 95%. The cluster
morphology did influence the calcium retrieval rate. There was a good
concordance of radiology and pathology opinion.
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Experience of quality assurance across BUPA
screening centres
P Hollaway
Radiation Protection Service, Royal Surrey County Hospital, Guildford,
Surrey, UK
Breast Cancer Research 2006, 8(Suppl 1):P17 (doi: 10.1186/bcr1432)
BUPA’s mammography quality assurance programme comprises an
annual audit visit to 31 hospital-based screening centres by one of a
team of three quality assurance mammographers. Clinical competence
and mammographic film quality are assessed and technical quality
control data are also collected. Monitoring of overall image quality is
also addressed by a ‘quarterly’ test object film. A patient dose survey
Breast Cancer Research    Vol 8 Suppl 1 Symposium Mammographicum 2006
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collected from all sites.
The standard of mammography across screening centres is good and
well within NHSBSP standards. Reject rates are less than 3% and are
personalised to each radiographer, enabling feedback and learning.
Continuing professional development is in place and sites have
evidence of a system of peer review. Quality control checks are
undertaken according to recommended standards and records are kept.
The mean glandular dose for a lateral oblique film across all centres
was 1.7 mGy, well below the recommended national reference dose
level. Mean doses at individual hospitals ranged from approximately
1.1 mGy to 2.3 mGy. Image quality scores using the Leeds TORMAM
are generally satisfactory and typical of elsewhere, with only a few films
having scores less than optimum and driving a move to higher contrast
film/screens at these sites.
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The Dutch experience of digital mammography in
screening
R van Engen
National Expert and Training Centre for Breast Cancer Screening,
Nijmegen, The Netherlands
Breast Cancer Research 2006, 8(Suppl 1):P18 (doi: 10.1186/bcr1433)
In The Netherlands a number of (screening) trials with digital mammo-
graphy have started. The first trial began in 1999, in which the
applicability of digital mammography was tested in a clinical
environment. For this purpose a GE Senographe 2000D was installed
in the Radboud University Nijmegen Medical Centre. The outcome of
this trial was positive. Therefore in 2002 a second trial started at a
static screening site in Utrecht with a Lorad Selenia system. In this trial,
digital mammography was evaluated in a screening environment with
its specific demands regarding workflow. In 2004 two more trials were
started with mobile digital screening units. In these trials, a Fuji FCR
Profect and an Agfa DM 1000 system were installed in the screening
units. This summer a new trial will start at a static screening unit in
Nijmegen in which digital mammography equipment from different
vendors (General Electric, IMS, Sectra, Planmed) will be installed to
test connectivity. Results of all trials will be presented with emphasis
on physical and technical aspects and workflow issues. Problems with
the mammography systems in the trials will be discussed. Besides this,
some experiences with digital mammography equipment in Dutch
hospitals will be discussed with emphasis on possible pitfalls.
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Ultrasound and fine needle aspiration assessment of
the axilla in patients with operable invasive breast
cancer
VR Stewart, L Meacock, A Ljutikov, D Evans, R Wasan, V Milnes,
N Akbar, N Dutt, H Li, MJ Michell
Kings College Hospital, London, UK
Breast Cancer Research 2006, 8(Suppl 1):P19 (doi: 10.1186/bcr1434)
Introduction  Axillary lymph node dissection has been standard
practice for staging invasive breast cancer. As sentinel lymph node
biopsy is being performed as an alternative less invasive procedure,
identification of positive axillary nodes by ultrasound (US) needle
biopsy is important in identifying involved axillae and thereby excluding
patients from inappropriate sentinel node procedures.
Method We evaluated the axilla of 71 patients with invasive breast
cancer and sampled abnormal nodes by the fine needle aspiration
(FNA) technique. Criteria for biopsy were cortex >2 mm, eccentrically
thickened cortex and loss of normal morphology. The results were
correlated with final histopathologic status after surgery.
Results Twenty-two out of 71 patients demonstrated abnormal nodes
on US, 12 of these 22 were malignant at surgery. In total, 18/71
patients had involved nodes at time of surgery; 9/18 were identified by
the US/FNA technique. Sensitivity, specificity, positive and negative
predictive values were 50%, 100%, 100% and 71%, respectively.
Conclusion US-guided FNA is a convenient method for identifying
involved axillary nodes. Axillary US alone would result in a significant
proportion of false-positive diagnoses.
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Wide local excision of breast carcinomas: the effect
of ultrasound and wire guidance on the Surgical
Precision Index
NPM Jain, CLE Osborne, CS Holgate, JR Steel, PA Jones,
RM Watkins
Primrose Breast Care Centre, Derriford Hospital, Plymouth, UK
Breast Cancer Research 2006, 8(Suppl 1):P20 (doi: 10.1186/bcr1435)
Aim To determine the effect of ultrasound and wire guidance on the
Surgical Precision Index (SPI) for wide local excision (WLE) of breast
carcinomas.
Methods  The SPI is calculated from the minimum excision margin
being divided by the total specimen weight (sw) to tumour diameter
(td) ratio (sw/td). The standard of surgical performance increases with
an increase in SPI. A review of histology reports provided SPIs for 97
WLE specimens in 96 patients treated by one surgeon. The mean SPIs
for palpable tumours, ultrasound-guided tumours and wire-guided
tumours were calculated.
Results There was a significant difference between palpable tumours
and impalpable tumours (Kruskal–Wallis test P = 0.007). There was no
significant difference between ultrasound-guided and wire-guided
WLEs (Mann-Whitney test P = 0.153).
Table 1 (abstract 20)
SPI by guidance technique
Technique Number Mean SPI Median Range
Palpable 44 1.91 1.67 0–8.08
Ultrasound 35 1.20 1.06 0–3.77
Wire 18 1.21 0.61 0–6.76
P = 0.007.
Conclusion  Palpable tumours have a higher SPI than impalpable
tumours. There is no statistically significant difference between the SPI
of ultrasound-guided and wire-guided WLEs.
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Audit of general practitioner referrals for breast pain
to rapid access breast clinics at North Cheshire NHS
Trust Hospital
C Jamieson, C Jonkers, L Robinson, A Sheridan
North Cheshire NHS Trust, Warrington, UK
Breast Cancer Research 2006, 8(Suppl 1):P21 (doi: 10.1186/bcr1436)
Purpose The audit was a retrospective study to examine the number of
general practitioner (GP) referrals for breast pain and to assess the
number of women imaged and the outcomes.
Methods Between 1 June and 31 December 2005 there were 945
referrals to the Rapid Access Breast Clinic (RABC), of which 222 were
for breast pain. Data collected included age, examination requested,
clinical information on imaging request, unilateral or bilateral pain,
status of requesting clinician and outcome.
Results Age range of referrals: under 35 years = 10%, 35–50 years =
56%, 51+ years = 34%. Of the 945 referrals, 23% were for breast pain.
Of the 222 women presenting with pain, 77% were imaged. Of the
number imaged, 83% had unilateral pain and 17% had bilateral pain.
The two consultant teams, each with either a registrar or SHO, showed
a significant difference in the amount of imaging requested. There were
118 mammograms and 56 ultrasound examinations requested.
Outcomes of imaging There were no malignancies detected. Ninety-
three per cent had no significant findings. Of the 7% with an abnor-
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incidental findings of microcalcification, and two asymmetrical densities
were proven normal.
Conclusion Of all the women referred to clinic, very few abnormalities
were detected (no cancers). Audit results have been disseminated to
Trust Consultants, and all referring GPs.
GPs should be supplied with local guidelines for the management and
referral of breast pain. They should be encouraged to give out
information booklets about breast pain.
There should be a consensus between all Breast Clinicians regarding
imaging criteria for breast pain.
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Feasibility of surgeon performing ultrasound in
symptomatic breast clinics: the Brighton experience
RS Rathinaezhil, C Zammit, G Rubin
Royal Sussex County Hospital, Brighton, UK
Breast Cancer Research 2006, 8(Suppl 1):P22 (doi: 10.1186/bcr1437)
Introduction Breast ultrasound (US) is becoming increasingly used by
surgeons in symptomatic breast clinics as an extended tool for
diagnosis and as an adjunct to interventional procedures.
Aim To assess the feasibility of surgeons performing breast US in
symptomatic breast clinics either as an adjunct to triple assessment or
on their own for diagnostic and therapeutic purposes.
Method We analysed the results of one surgeon performing diagnostic
and interventional US procedures after appropriate training as
recommended by the Royal College of Radiologists and the support of
a local radiologist between January 2004 and April 2005. One hundred
and fifty-six patients underwent an US scan either on its own or as part
of the triple assessment.
Results See Table 1.
Table 1 (abstract 22)
72 patients (46%) had US only  69 patients (96%) had normal findings 
without needle procedure (as not  and three patients (4%) had 
deemed necessary on clinical  indeterminate or suspicious results 
grounds on first visit) subsequently downgraded by the 
radiologist
50 patients (32%) had US with fine  49 patients (98%) had benign lesions 
needle procedure (60% cysts, 40% solid) and one patient 
(2%) had a suspicious lesion, 
downgraded
21 patients (13%) had US with wider  14 patients (67%) had malignant 
needle procedure lesions, three patients (14%) had 
indeterminate lesions and four patients 
(19%) had benign lesions
Nine patients (6%) had US to assess  In addition to clinical assessment
response to endocrine treatment
Four patients (3%) had US not double  Two patients had normal scans, one 
reported by the radiologist patient had fibroadenoma removed 
surgically and another had 
gynaecomastia
Conclusion Of the three patients (2%) who had a recall by the
radiologists, no cancer was missed. With appropriate training and
support by the radiologist, and auditing one’s performance, surgeons
can safely perform US scans in the breast clinic.
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Medico-legal aspects of delay in breast cancer
diagnosis: the surgeon’s perspective
HM Bishop
Royal Bolton Hospital, Bolton, Lancashire, UK
Breast Cancer Research 2006, 8(Suppl 1):P23 (doi: 10.1186/bcr1438)
Delay in the diagnosis of breast cancer is a frequent cause of patients
seeking redress through the Courts. Patients are naturally fearful that
the delay has reduced their survival. If they feel that their original assess-
ment was in some way casual or superficial, they are often angry.
In the clinic, surgeons have to decide whether a patient has a true lump
or not. This is often difficult, and particularly so for trainees. Never-
theless, the surgeon or breast physician must discipline themselves to
formally characterise a symptomatic breast abnormality. This should be
done by using the standard breast industry classification of 1–5. In this
situation, P for palpability precedes the number.
Surgeons will be assisted by their radiologists, who are able to offer a
very high level of imaging support.
The problem that arises is when a surgeon or clinician identifies a lump
and the radiologist is unable to identify the lump at imaging. It should
be remembered that approximately 15% of breast cancers are mammo-
graphically occult.
In a recent case, a woman had an 8 cm lump in her breast. The
radiologist reports a normal mammogram. Over the next 2 years five
different junior doctors observe this lump. Finally, the patient sought a
second opinion for her 8 cm Grade I cancer. Why did this occur?
The radiologist was a consultant, the requesting clinician was a (locum)
junior. There is a natural tendency to rely on technology, which is
usually better than a clinical examination — but not always.
Consultant breast radiologists can appear intimidating to junior
doctors. If that junior doctor is working in a poorly organised surgical
breast clinic, then there is a potential for mistakes to occur.
The solution is to have the diagnostic process in your breast unit so
organised that risks such as these are reduced to a minimum.
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Medico-legal aspects of delay in breast cancer
diagnosis: the radiologists’ perspective
R Wilson
Breast Institute, City Hospital, Nottingham, UK
Breast Cancer Research 2006, 8(Suppl 1):P24 (doi: 10.1186/bcr1439)
The increasing importance of breast imaging in the diagnosis of breast
problems and the use of mammography in screening now mean that
breast radiologists are very much in the front line for medico-legal
action. Breast imaging is now the commonest reason for a radiologist
to be involved in medico-legal investigations. The reason is almost
always an alleged delay in diagnosis. In symptomatic practice this
usually involves alleged failure to carry out the appropriate imaging
investigation, including image-guided biopsy, while in screening
practice this usually involves failure to detect the early signs of breast
cancer. These arise out of the unrealistic expectations of patients about
the diagnosis of breast cancer. Measures to reduce the risks of
medico-legal investigation are simple and straightforward.
Recent emphasis on informed consent by the GMC means that
radiologists, like all others involved in patient care, are required to
provide patients with the full facts on which these patients can base
their decisions. It is important to ensure that the radiological aspects of
care are formally documented, including the content and results of
discussions at multidisciplinary meetings.
The Bolam test increasingly cannot be considered an adequate defence;
if the court considers it bad practice then it does not matter how many
doctors practice the same way. However, both symptomatic and
screening practice are now the subject of detailed clinical protocols;
provided these are in place and are strictly followed, then proof of
substandard care is difficult. In addition, double reading is now largely
standard practice in screening and there is a wealth of data to inform
medico-legal investigations about the limitations of screening practice.
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Medico-legal aspects of delay in breast cancer
diagnosis: the legal perspective
M Spencer QC
Hailsham Chambers, Temple, London, UK
Breast Cancer Research 2006, 8(Suppl 1):P25 (doi: 10.1186/bcr1440)
In English law, there is no strict liability in relation to the failure of a
doctor to diagnose breast cancer, but, in order for a Claimant to
succeed, it is necessary for her to prove negligence. The courts apply
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been negligent, as modified in Bolitho v City and Hackney Health
Authority. Example: Adekanmbi (deceased) v Allinson (2004).
Where there has been a delay in diagnosis of breast cancer, the
challenge is often in relation to causation, showing what the outcome
would have been if the diagnosis had been made when it ought to have
been. English law does not recognise loss of a chance in personal
injury actions and causation is decided on the balance of probabilities
(Gregg v Scott). Where a woman dies of breast cancer after a
negligent delay in diagnosis, the question is whether she would have
survived had the diagnosis been made. This may depend on the
appropriate staging of the carcinoma at the relevant time, again
decided on the balance of probabilities. Alternatively, the claim may be
that earlier diagnosis would have avoided chemotherapy, or the
cosmetic outcome would have been better. Example: K v Dr B (2005).
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Image-guided breast biopsy programme quality
evaluation
F Burbank
Laguna Niguel, California, USA
Breast Cancer Research 2006, 8(Suppl 1):P26 (doi: 10.1186/bcr1441)
Image-guided breast biopsy programs are a clinical reality at breast
care centers throughout the world. Because image-guided biopsy is a
departure from traditional surgical breast biopsy, the quality of each
new image-guided breast biopsy program should be measured. A
generalized scheme for quality evaluation will be presented.
The most complex part of this scheme is the comparison of tissue
samples obtained by image-guided biopsy with tissue samples
subsequently obtained during surgery. Because image-guided biopsy
programs retrieve histology specimens that are microscopically as valid
as histology obtained from open surgery, comparing the histology from
an image-guided breast biopsy with the histology from an open surgical
biopsy is complex. One cannot use the well-known method of
determining false-negative and false-positive rates. In addition, breast
histology, itself, is quite complex. Some benign breast disease is quite
focal and specific, such as fibroadenomas. Other benign breast disease
is diffuse and not very specific, such as fibrocystic abnormalities.
Furthermore, malignant breast disease is part of a histology spectrum
starting with normal-looking breast tissue with atypical features,
progressing to carcinoma in situ, and ending, finally, with infiltrating
breast cancer. To illustrate how histological comparisons should be
made for breast tissue, published results from a large, nationally funded
study will be re-examined using the proposed scheme.
Although the breast biopsy, itself, may seem like the hard work of a
new breast biopsy program, it is not. After the first year of the program,
follow-up of women who have been biopsied is the true, back-breaking,
hard work. How a breast center should perform air-tight follow-up will
be described.
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Update on breast cancer genetics
L Izatt
Guy’s and St Thomas’ Hospital, NHS Trust, London, UK
Breast Cancer Research 2006, 8(Suppl 1):P27 (doi: 10.1186/bcr1442)
The breast and ovarian cancer susceptibility genes BRCA1 and
BRCA2 were identified over 10 years ago. Development and
expansion of cancer genetics services across the United Kingdom
coupled with advances in genetic technology and investment from the
government White Paper ‘Our Inheritance, Our Future’ have increased
demand and access for diagnostic genetic testing of BRCA1 and
BRCA2. NICE guidelines from 2004 recommend that individuals with a
>20% risk of having a mutation should be offered comprehensive
diagnostic  BRCA1 and  BRCA2 mutation testing. This now detects
over 95% of all mutations, as well as variants of unknown significance.
BRCA1 and  BRCA2 carriers face complex decisions regarding
screening and risk-reducing options in a rapidly changing field and may
benefit from a multidisciplinary approach to their care. However, the
majority of breast-cancer-only families will have no BRCA1 or BRCA2
mutation identified on diagnostic gene testing. Research studies to
identify further breast cancer susceptibility genes are ongoing.
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NICE family history guidance and implementation
update
J Mackay
Institute of Human Genetics and Health, University College London, UK
Breast Cancer Research 2006, 8(Suppl 1):P28 (doi: 10.1186/bcr1443)
The National Institute of Clinical Excellence and Health (NICE) released
guidance to the NHS on the management of familial breast cancer in
May 2004. In that guidance [1] several statements of important clinical
relevance were made. There seems to have been a lag between the
time of release and implementation in many areas of the country.
Important guidance on the detailed provision of BRCA1 and BRCA2
genetic testing services was included. Cancerbackup performed a
survey of NHS clinical genetics services and NHS laboratory services
at the end of 2005. The findings of this survey were released to the
public at a workshop entitled ‘BRCA testing: opening the dialogue’,
which was held at University College London on 14 December 2005.
An update on the findings of this survey will be presented to the
conference.
Several recommendations were also made about the provision of
regular mammographic services for women under 50 with a family
history of breast cancer. It has become clear to the team developing
and leading FH01 that service provision across the United Kingdom is
very patchy and there appears to be significant geographical variation
in the level of service the public can expect. We will examine some of
that variation and consider whether mechanisms should be put in place
to monitor service provision more closely.
Reference
1. Clinical Guidelines and Evidence Review for the Classification
and Care of Women at Risk of Familial Breast Cancer. London:
National Collaborating Centre For Primary Care/University of
Sheffield; May 2004.
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Update on the FH01 study
SW Duffy
Wolfson Institute of Preventive Medicine, London, UK
Breast Cancer Research 2006, 8(Suppl 1):P29 (doi: 10.1186/bcr1444)
FH01 is a single-arm study of annual mammography in women aged
40–49 with a moderate family history of breast cancer. Originally, it
was planned to recruit 10,000 women but this has been revised to
6,000. In this presentation we summarise the considerations that
informed the study and its design, the problems encountered and the
progress of the study so far. Implications for future studies in specific
risk groups are discussed.
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Update on magnetic resonance screening and the
MARIBS trial
R Warren
Department of Radiology, Addenbrooke’s Hospital, Cambridge, UK
Breast Cancer Research 2006, 8(Suppl 1):P30 (doi: 10.1186/bcr1445)
Genetically predisposed women often develop breast cancer when
young and when dense breast tissue reduces the sensitivity of X-ray
mammography (XRM). A UK multicentre study comparing the perfor-
mance of contrast enhanced magnetic resonance imaging (CE MRI)
with XRM in these women commenced in 1997 and reported 2005.
In this multicentre study, CE MRI was significantly more sensitive than
XRM in cancer detection for the entire cohort, but especially in the
subgroup of BRCA1 carriers. Specificity for both procedures was
acceptable. Despite a high proportion of Grade 3 tumours, the tumours
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resemble the results from the Netherlands six-centre MRISC study and
a single-centre study from Toronto. These studies give support for a
policy of annual screening combining CE MRI and XRM, which would
detect most tumours in this risk group. These studies show evidence of
effective small cancer detection, but do not have sufficient power to
show whether mortality is reduced, for which there is no current
evidence.
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Workforce issues in breast imaging: radiographers as
screen readers
RL Bennett, RG Blanks, SM Moss
Cancer Screening Evaluation Unit, Institute of Cancer Research,
Sutton, Surrey, UK
Breast Cancer Research 2006, 8(Suppl 1):P31 (doi: 10.1186/bcr1446)
The expansion of the National Health Service Breast Screening
Programme (NHSBSP) has increased workload, adding to existing
pressure on resources due to a shortage of radiologists. As a result
some units have introduced double reading by two radiographers, with
arbitration by a radiologist or breast clinician. Although some
experimental work has supported such a move, the Advisory Committee
on Breast Cancer Screening has requested further evidence from a real-
life setting to support this change in reading practice.
An observational study was initiated in 2004. A questionnaire was
developed to document annually the reading practices of all screening
units, and number of years of experience of individual film readers.
Information gathered from the questionnaires, together with routine
data from the KC62s, will allow us to compare the performance of units
using radiographer-only double reading with that of other units. We will
also be able to compare the performance before and after the change
in reading protocol for units moving to radiographer-only double
reading. The main outcome measures of performance will be cancer
detection rates, standardised detection ratios and recall rates.
32
Workforce issues in breast imaging: the consultant
radiographer’s perspective
E Dean
North Tees Breast Unit, Stockton-on-Tees, UK
Breast Cancer Research 2006, 8(Suppl 1):P32 (doi: 10.1186/bcr1447)
In my experience the consultant radiographer within the breast services
provides a similar role and clinical level of responsibility as that of the
medical breast specialist. All professionals within such a role require
the knowledge, skills and expertise to provide a high quality of service
for all its users.
The position has provided a key person who is used as a supportive
resource for all the members of the multidisciplinary team. The
consultant radiographer role has helped to enhance communication not
only within the team, but also for the clients and patients and across
other service boundaries.
It has helped to promote the service and the sharing of good practice
within the service, which in turn will enrich the service as a whole.
Recruitment and retention of the staff is essential to the continued
success of the service. The new training and educational pathways and
recognition of the staff can only be of benefit to the service.
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Workforce issues in breast imaging: the consultant
radiologist’s perspective
A Hubbard
Hull and East Yorkshire Breast Care Unit, Castle Hill Hospital,
Cottingham, Yorkshire, UK
Breast Cancer Research 2006, 8(Suppl 1):P33 (doi: 10.1186/bcr1448)
Consultant radiologists are still deeply divided in their opinions about
advanced practice, many still having concerns about clinical
governance and the training and supervision needed. I have used a
small questionnaire to obtain a ‘snapshot’ of breast screening units
who use radiographer advanced practitioners, what they do, whether
they replace or just augment the functions of a consultant radiologist,
and the opinions of the radiologists working alongside them.
Advanced practice means more than just a means to enable second
reading of films. Without continuous feedback, involvement in assess-
ment and support, this can become a boring task, with skill levels and
motivation difficult to sustain. Increasingly, in many units practitioners
are replacing other aspects of the traditional role of the consultant
radiologist. Almost all advanced practitioners are film readers, but many
have extended their roles further and now also do stereo tactic biopsy,
ultrasound and ultrasound-guided biopsy, clinical examination, and
localisation of impalpable tumours. We need to encourage the many
eligible units who could participate in the current trial of radiographer-
only screen film reading to join, in order to provide concrete evidence
that radiographers are as good as radiologists in real-life practice.
With consultant radiologist posts becoming a little easier to fill than
previously, we need to examine this role more carefully and decide
what benefits practitioners can bring to a unit, and how to make this
role a fulfilling and secure one for our radiographers in the future.
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Hormones and radiation as risk factors for breast
cancer
V Beral
Cancer Epidemiology Unit, University of Oxford, UK
Breast Cancer Research 2006, 8(Suppl 1):P34 (doi: 10.1186/bcr1449)
Abstract not submitted.
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Breast surgery: state of the art
M Kissin
Mount Alvernia Hospital, Guildford, Surrey, UK
Breast Cancer Research 2006, 8(Suppl 1):P35 (doi: 10.1186/bcr1450)
Abstract not submitted.
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Oncology update: what do all those acronyms mean?
L Hughes-Davies
Department of Oncology, Addenbrooke’s Hospital, Cambridge, UK
Breast Cancer Research 2006, 8(Suppl 1):P36 (doi: 10.1186/bcr1451)
This presentation will review ongoing clinical research in breast
oncology across the United Kingdom, briefly summarising the rationale
for each trial and including an update on the current enrolment status.
UK trials will be compared with breast cancer trials running in other
countries, many of which have a similar design. Particular attention will
be paid to the final results from the NEAT trial, which will have
appeared in the New England Journal of Medicine immediately before
the conference started. The NICE panel’s ruling on adjuvant taxanes
has also just appeared and this will be also be presented. The talk will
end with a review of important questions that remain unanswered in
breast oncology and a discussion of the trials that are currently on the
drawing board to answer these questions.
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A brief history of breast medicine
L Lunt
Breast Screening & Assessment Centre, Queen Elizabeth Hospital,
Gateshead, Tyne & Wear, UK
Breast Cancer Research 2006, 8(Suppl 1):P37 (doi: 10.1186/bcr1452)
Hippocrates believed that treating ‘hidden cancers’ did more harm than
good. Today we debate whether we are over-treating some screen-
detected lesions. History really does repeat itself.
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physicians to cure breast cancer: from ancient potions and poultices,
through centuries of brutal but swift surgery, to the supraradical
mastectomy of the early twentieth century, on to conservative surgery
with adjuvant therapies. Attitudes and beliefs of patients have
influenced the management of breast cancer, from quiet acceptance of
extreme suffering to the vocal feminist fury against ‘mutilation’ by male
surgeons in the 1970s.
The quest for early detection and accurate diagnosis produced a
variety of imaging techniques. Some of them, thankfully, have now been
forgotten. The NHS Breast Screening Programme, now in its 19th year,
has brought rapid and radical change to breast cancer care in the
United Kingdom.
The difference between brilliant advances and heroic failures can only
be judged by history.
38
Abstract withdrawn.
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Calcification or artefact? A case study examining
potential products which can mimic calcification in
mammography
A Andersen, N Etheridge, S Harridge, S Llewelyn
Jarvis National Breast Screening, Training and Diagnostic Centre,
Guildford, UK
Breast Cancer Research 2006, 8(Suppl 1):P39 (doi: 10.1186/bcr1454)
This poster is a case presentation of a woman who was recalled from
breast screening with suspicious microcalcifications. Follow-up
mammograms revealed that it had been an artefact on the skin surface.
The cause of this artefact was unknown and this poster attempts to
identify a product that may have caused this calcific-like artefact.
Previous research [1,2] highlights the potential problems associated
with the use of deodorants and antiperspirants on mammographic
interpretation. These studies demonstrate the association of the use of
underarm deodorants with calcific-like artefacts. This poster not only
examines deodorant as a possible source of the artefact, but also
identifies other products as probable causes. Five products in total
were used: stick deodorant, talc, body scrub, paint and body glitter.
Samples of each of these were individually X-rayed using an
anthropomorphic breast phantom.
The subsequent films were compared with the original X-ray and one of
the products was identified as the most probable cause of the artefact.
As a result of this research, products not previously considered as
potential causes of artefacts were identified. Our results are presented
in a light-hearted format.
References
1. Young et al., 2002.
2. Barton, 1990.
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An audit of preoperative magnetic resonance
imaging staging of the breast
M Bagnall, AE Turnbull
Derby Hospitals Foundation Trust, Derby, UK
Breast Cancer Research 2006, 8(Suppl 1):P40 (doi: 10.1186/bcr1455)
Background  In Derby, preoperative magnetic resonance imaging
(MRI) breast tumour staging is used in selected cases (e.g. occult
tumour on standard imaging, lobular core histology).
Methods  We present 45 initial patients undergoing breast MRI for
local staging identified between January 2001 and December 2004. All
cases were potentially suitable for wide local excision (WLE) after
standard triple assessment (using the local protocol of 30 mm size cut-
off for conservative surgery).
Results Twenty-five cases were advised suitable for conservative
treatment after MRI (20 undergoing WLE all showing clear margins).
Five cases after MRI were not definitive (offered choice). Fifteen cases
of mastectomy were suggested after MRI and further conventional
imaging (nine cases tumour >30 mm at mastectomy, one undergoing
neoadjuvant chemotherapy, two cases tumour <30 mm but with extensive
DCIS, three cases multifocality at MRI not identified pathologically).
Adherence to available standards To date no local recurrences have
been identified in conservatively treated patients (NHSBSP target 10%
recurrence at 5 years for DCIS). Forty-three out of 45 (95.5%) patients
underwent a single therapeutic operation (NHSBSP target 90% of
women should not require more than one therapeutic operation to
ensure complete excision). Results will be discussed in particular for
those cases where MRI and surgical pathology did not correlate.
41
Reducing our recall to assessment rate in the
prevalent round to achieve the NHSBSP QA Standard
JM Leadbetter, CH Beattie
Breast Screening Unit, Royal Liverpool and Broadgreen University
Hospitals NHS Trust, Liverpool, UK
Breast Cancer Research 2006, 8(Suppl 1):P41 (doi: 10.1186/bcr1456)
Since 1999, the proportion of prevalent round women recalled to
assessment in the Liverpool NHSBSP has steadily increased —
peaking at 17/1,000, almost double the minimum QA Standard.
We have a total of 10 film readers and have always double-reported
with arbitration (by a single radiologist). Our sensitivity has been good
with an SDR and a small cancer detection rate within the target QA
standard.
Factors perceived as problematic were the increasing number of
readers, a high proportion of inexperienced readers, combinations of
cautious readers and lack of discussion.
At the beginning of 2005 we adopted a new arbitration system. All
prevalent round patients recalled by at least one film reader had their
films reviewed by a minimum of three film readers, including at least
one radiologist. This system was extended to include all incident round
patients referred to arbitration. Recall rates and cancer detection rates
were audited for 12 months.
We have now achieved a recall rate of 7.1/1,000 with no reduction in
the cancer detection rate. Other benefits include an increased capacity
in assessment clinics to accommodate age extension, reduced patient
anxiety, better team working and a complimentary reduction in recall
rates for incident round women.
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A radiographer-delivered intervention to promote
early presentation of breast cancer among women as
they leave the routine protection of the NHS breast
screening programme
C Burgess1, L Omar1, M Hunter1, A Bish1, MJ Michell2, G Kirby2,
P Whelehan2, A Ramirez1
1Cancer Research UK London Psychosocial Group, Institute of
Psychiatry/Kings College, London, UK; 2South East London Breast
Screening Programme & National Training Centre, London, UK
Breast Cancer Research 2006, 8(Suppl 1):P42 (doi: 10.1186/bcr1457)
Older age is a risk factor both for developing breast cancer and for
delayed presentation of the disease. Routine breast screening on the
NHSBSP, however, ends at age 70. Our aim was to develop a
radiographer-delivered psycho-educational intervention to be delivered
at the point when the women leave the routine protection of the
NHSBSP in order to: increase women’s knowledge about breast
symptoms and risk, promote disclosure of symptoms to someone
close, reduce perceptions of barriers and increase intentions to seek
help, and counter the interpretation by older women that their risk of
breast cancer diminishes once routine screening ends.
The ultimate aim of the intervention is to reduce the proportion of older
women with breast cancer who delay their presentation, and to thereby
save lives.
We report the development of two variants of the intervention: a
booklet and a 10-minute, radiographer-delivered, interview plus the
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South East London Breast Screening Programme and been shown to
be acceptable and feasible to women and the Programme. A
randomised controlled trial is planned to assess the effect of the
intervention on delayed presentation and survival.
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Using an aubergine as a phantom for practicing
stereotactic guided core biopsy
C Chapman, G Rubin
Royal Sussex County Hospital, Brighton, UK
Breast Cancer Research 2006, 8(Suppl 1):P43 (doi: 10.1186/bcr1458)
Introduction Practitioners learning how to perform stereotactic guided
core biopsies need a nonhuman model to practice on. This presentation
demonstrates a technique using contrast medium mixed with ink
injected into an aubergine as a phantom to practice on, which has
subsequently been used by the Jarvis Centre for teaching stereotaxis.
Equipment  (1) Black ink. (2) Any water-soluble contrast medium
(preferably life expired). (3) A green needle to draw up ink and contrast
medium and a 2 ml syringe. (4) A long orange needle to inject into the
aubergine. (5) An aubergine. (6) A biopsy device and needle.
Technique (1) Mix the ink and contrast medium. Inject the aubergine
with a fine trail of black ink. Do not be heavy handed, you need very
little — 0.5 ml at the most. (2) Turn the aubergine over 90° and place on
the stereotactic table so that the line of ink is parallel to the table top.
(3) Position as for a normal stereo and carry out the procedure as
normal, including taking check pictures. (4) You will see immediately
from the samples whether you have ‘hit the spot’ as you have black ink
within the sample. It is possible to X-ray the sample to confirm this. 
(5) Do not send to pathology!
Pros Simple cheap and easy. Do not have to practice on a patient but
become proficient at using the equipment — no pain, lots of gain!
Cons Not a perfect mimic of dots of calcification. Do not have the
practice of adapting to patient movement. Risk of getting ink on hands
and clothing.
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Women’s satisfaction with clinical nurse specialists
at assessment clinics within the West Midlands
Breast Screening Programme
J Chapman, E O’Sullivan, O Kearins, G Lawrence
West Midlands Cancer Intelligence Unit, Birmingham, UK
Breast Cancer Research 2006, 8(Suppl 1):P44 (doi: 10.1186/bcr1459)
Due to lack of specific guidance as to how clinical nurse specialist
(CNS) standards should be monitored, the West Midlands Breast
Screening QA Reference Centre together with a CNS working party
developed a tool to assess the role of the CNS in assessment clinics
within the region. The audit was designed to determine a woman’s
satisfaction with the service offered by CNSs.
Survey forms were issued to all women attending a breast screening
assessment clinic during March 2005, irrespective of whether or not
they met with a CNS. An overall response rate of 62% was achieved.
Ninety-two per cent of women had contact with a CNS at some point
during the assessment process. Of these, 99% found it to be a
valuable experience. Only three women felt that talking to a CNS was
of no benefit to them. Sixty-five per cent had the CNS contact details
provided prior to attending the assessment clinic, and 61% were given
contact details for a CNS on the day of their assessment for follow up
discussions.
Five per cent stated that discussions with the CNS were not held in a
private room. It would appear that women found written information
easier to understand (85%) than verbal (53%).
Service-specific comments and suggestions have been fed back to
assist in service improvement. The audit will be repeated in 2006.
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Workload analysis for clinical nurse specialists
working in breast screening
J Chapman, E O’Sullivan, O Kearins, G Lawrence
West Midlands Cancer Intelligence Unit, Birmingham, UK
Breast Cancer Research 2006, 8(Suppl 1):P45 (doi: 10.1186/bcr1460)
To accurately evaluate the role of the clinical nurse specialists (CNS) in
breast screening assessment clinics, baseline information regarding
patient throughput and interactions with the CNS were required.
Following every screening assessment clinic in the West Midlands,
each CNS in attendance completes a short audit form that covers the
number of women attending the clinic, the number seen by the CNS,
for those not seen the reason for this, and the time the CNS arrived
and left the clinic.
For the period April 2004–March 2005 an average of seven women
attended each assessment clinic (range: 3–14). The average time
spent in the clinic was 2:31 hours (range: 0:10–9 hours). Seventy-six
per cent (4,515/5,951) of women attending had contact with a CNS
(range: 18–100%). Of the 1,436 women who did not have contact
with a CNS, reasons were given for 1,403. The main reasons were that
the CNS was occupied with another patient (44%) or it was patient
choice (37%).
From research into patient satisfaction with the CNS, it is known that,
for women attending for assessment, interaction with a CNS is
perceived to be highly beneficial. Managers should try to ensure that
sufficient CNSs are available to give all women attending for
assessment the opportunity to see a CNS.
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West Midlands Breast Screening General Practice
Information Pack
J Chapman, E O’Sullivan, O Kearins, G Lawrence
West Midlands Cancer Intelligence Unit, Birmingham, UK
Breast Cancer Research 2006, 8(Suppl 1):P46 (doi: 10.1186/bcr1461)
In 2004 the West Midlands Breast Screening Health Promotion Group
developed a standardised General Practice Information Pack that can
be sent out by breast screening services to all general practices, prior
to their eligible women being invited for screening. The purpose was
twofold. Firstly, to be an educational tool for practice staff to update
their knowledge of breast screening to ensure that they can deal with
women’s queries. Secondly, to promote the importance and value of
breast screening to practice staff in the hope that they would be
proactive in encouraging women within their catchment area to attend
for breast screening.
The pack consists of 11 fact sheets providing information such as:
contact details for the screening service; where and when women will
be screened; key facts about breast screening; statistics for the
screening service, general practice and PCT; frequently asked
questions; and useful contacts for information and resources.
Along with the Information Pack, services were sent an evaluation form
and a pre-paid envelope addressed to the West Midlands Breast
Screening QA Reference Centre. To date 52 forms have been returned.
Eighty-five per cent of respondents found the pack very useful. In
particular they welcomed information on age ranges, contact details,
practice statistics, frequently asked questions and answers, and
information about the availability of leaflets and posters.
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Pathology quality assurance: the use of control charts
E O’Sullivan, J Chapman, N Tappenden, O Kearins, G Lawrence
West Midlands Cancer Intelligence Unit, Birmingham, UK
Breast Cancer Research 2006, 8(Suppl 1):P47 (doi: 10.1186/bcr1462)
Breast Screening Quality Assurance Reference Centres have a
responsibility to monitor the performance of breast screening services
and to feed relevant outcome data back to them. In order to be useful,
this feedback has to be meaningful and easily interpretable. Past
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particularly difficult to achieve for pathology data using conventional
analytical methods. With this in mind, it was decided to assess the
usefulness of control charts.
Control charts demonstrate acceptable and unacceptable variation.
Acceptable variation is known as common cause variation and is
deemed to be due to natural chance. The only way to reduce this type
of variation is to remodel the whole process. Special cause variation is
an exceptional variation that needs to be investigated to identify the
cause. When examining reasons for special cause variation, the data
are first checked for accuracy. The case mix is then reviewed, followed
by processes and resources, and finally the individuals involved.
In Figure 1, the dots represent the proportion of Grade 2 breast
cancers reported by West Midlands pathology laboratories. The
reporting rate in the laboratory represented by the larger dot lies
outside the common cause variation limits when compared with other
laboratories. Work will be undertaken with this laboratory to identify the
reasons for the special cause variation evident in these data.
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Audit of short-term recall in the National Health Service
Breast Screening Programme in the West Midlands
MG Pritchard, O Kearins, G Lawrence
West Midlands Cancer Intelligence Unit, Birmingham, UK
Breast Cancer Research 2006, 8(Suppl 1):P48 (doi: 10.1186/bcr1463)
In the NHS Breast Screening Programme, cases where some
diagnostic uncertainty remains following assessment may be recalled
for a further appointment. Short-term recall (STR) rates and recall
periods vary between screening services. There is a lack of published
material to suggest who will benefit most from an STR appointment.
Data were collected from the screening folders for 110 women put on
STR following assessment, and for three women put on STR from STR
in the financial year 2003/2004. The data collected included
radiological appearance and opinion, biopsy results, reason for STR,
and outcome.
The most frequent reasons for women being put on STR were patient
choice (18 cases, 16%), difficulty in biopsy (11 cases, 10%) and low
yield of calcification in biopsy specimens (eight cases, 7%). The most
frequent characteristics were calcification, benign or uncertain
radiological appearance and a B1 (normal breast tissue) biopsy.
At STR, 92 cases (84%) were found to be benign and returned to
routine recall. Four women (3.6%) had invasive cancer, one woman
had ductal carcinoma in situ, two women had a further 12-month STR
and two women had open biopsy. For nine women (8%), the outcome
of the STR appointment was unknown. The four invasive tumours were
all from incident screens, one each of asymmetric distortion, micro-
calcification, radial mass and appearance not recorded. From the three
women on STR from STR, an additional invasive cancer was found and
two women were returned to routine recall.
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Modelling of the impact of replacing four-node
sampling with sentinel lymph node biopsy within the
NHS Breast Screening Programme
CS Cheung, O Kearins, H Davis, G Lawrence
West Midlands Cancer Intelligence Unit, Birmingham, UK
Breast Cancer Research 2006, 8(Suppl 1):P49 (doi: 10.1186/bcr1464)
The aim of this study was to use the Association of Breast Surgery at
the British Association of Surgical Oncology audit data to model the
possible consequences of the rollout of sentinel lymph node biopsy
(SLNB) across the NHS Breast Screening Programme. The lymph
node status, invasive size, grade and number of operations were
examined for 26,431 screen-detected invasive cancers diagnosed in
women who were invited for screening between 1 April 2001 and 31
March 2004.
Seventy-five per cent of screen-detected invasive breast cancer had a
negative nodal status. The average number of nodes removed in these
cases was 10. If these cases had had their axilla assessed using
SLNB, then the majority of women diagnosed with screen-detected
breast cancer would have had a minimally invasive axillary procedure.
Assuming that the protocol utilised during the ALMANAC study was
continued, the 25% of cases with positive lymph nodes would require a
second operation to clear the axilla. This would represent a 20%
increase in the number of cases requiring a second therapeutic
operation. In addition, as over 80% of these cases had less than five
positive nodes found, a full axillary clearance may be overtreatment.
Analysis of the variation of lymph node positivity with size and grade
demonstrates that these factors could be used to determine which
women with a positive sentinel lymph node require a full axillary
clearance and which women could be appropriately managed with a
level 1 clearance, thus reducing the possible complications of lympho-
edema.
50
The Sloane Project: a UK prospective audit of screen-
detected non-invasive carcinoma of the breast
K Clements1, O Kearins1, G Lawrence1, H Bishop2
1West Midlands Cancer Intelligence Unit, Birmingham, UK; 
2Royal Bolton Hospital, Bolton, UK
Breast Cancer Research 2006, 8(Suppl 1):P50 (doi: 10.1186/bcr1465)
The Sloane Project is a national prospective audit of women with
screen-detected non-invasive breast carcinoma, inviting participation
from all 98 UK Breast Screening Units.
The aim of the Sloane Project is to gain knowledge regarding the
diagnosis, treatment and clinical outcomes of screen-detected carci-
noma  in situ and atypical hyperplasias. Particular characteristics in
terms of the radiological and pathological appearance and their
significance in terms of outcome are collected, together with details of
surgical and adjuvant treatment, via specifically designed data forms.
Currently 57 breast screening units are submitting data, and data for
more than 2,000 cases have been recorded to date. Variations in the
management of this disease are already apparent from these data, with
varying approaches to the use of wide local excision (WLE) and
mastectomy (72.8% vs 27.2%) and with nodes being removed in
5.87% of WLE cases and 72.49% of mastectomy cases. Differences
in clinical management are also apparent for adjuvant therapy, with the
proportion of cases being referred for radiotherapy varying between
breast screening units from 0% to 76.47% and the use of hormone
therapy varying from 0% to 78.87%.
These data reinforce the need for a large-scale study of DCIS so that
reliable clinical protocols for the optimal management can be
developed.
Available online http://breast-cancer-research.com/supplements/8/S1
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Radiotherapy for screen-detected ductal carcinoma in
situ: indications and utilization in the United
Kingdom — findings from the Sloane Project
D Dodwell1, K Clements2, WD George3, G Lawrence2, H Bishop4
1Cookridge Hospital, Leeds, UK; 2West Midlands Cancer Intelligence
Unit, Birmingham, UK; 3Western General Infirmary, Glasgow, UK;
4Royal Bolton Hospital, Bolton, UK
Breast Cancer Research 2006, 8(Suppl 1):P51 (doi: 10.1186/bcr1466)
There is an increasing use of wide local excision (WLE) in preference
to mastectomy as the definitive surgical therapy. A number of
randomised control trials (RCTs) have confirmed that postoperative
whole-breast breast irradiation (RT) following WLE of DCIS reduces
the risk of in situ and invasive recurrence. Available RCTs do not
readily allow the identification of patients who would benefit most from
RT, or conversely do not require RT.
Of 870 patients who underwent WLE for DCIS, 453 were referred for
RT. The use of RT following WLE was correlated with pathological
characteristics and margin status. The use of RT varied with tumour
size, nuclear grade and the presence of necrosis, but not with margin
size. There was a good correlation with Van Nuys Score, supporting
the use of this scoring system in routine practice to predict the
potential benefits of referral for RT.
Table 1 (abstract 51)
Received  Did not receive 
radiotherapy radiotherapy
Margin
<1 mm 34 36
1–9 mm 152 111
≥10 mm 129 100
Size
≤15 mm 161 213
16–40 mm 153 58
≥41 mm 14 5
Grade
High 243 95
Intermediate 83 126
Low 12 57
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Analysis of QA Team visit recommendation
responses in order to find ways of improving the
probability of completion
R Davies, O Kearins, G Lawrence
West Midlands Cancer Intelligence Unit, Birmingham, UK
Breast Cancer Research 2006, 8(Suppl 1):P52 (doi: 10.1186/bcr1467)
The Commission for Health Improvement report into the West of
London Breast Screening Service recommended that a formal
structure for the follow up of recommendations made at quality
assurance (QA) visits should be implemented.
In the West Midlands, breast screening services are visited every
3 years as part of a rolling programme. Ad hoc visits can occur during
this period to a service or one or more disciplines if there are issues or
concerns with a particular aspect of a service. Following a QA Team
visit, a breast screening service can expect 3-month and longer term
recommendations, and occasionally immediate recommendations,
which highlight areas that require action to improve service delivery.
In order to allow structured follow-up, recommendations are classified
into the following disciplines; administration and clerical, radiography,
radiology, medical physics/user QA, pathology, surgery, nursing and
management. A detailed process has been put into place that tracks
the receipt of recommendation responses from the service, which
allows completed recommendations to be analysed by discipline, type
and time to completion.
This detailed analysis can be used to identify which recommendations
are completed effectively and within the set timescale, to identify which
types of recommendations take longer to complete than anticipated,
and to identify ways in which the arrangement and/or wording of
recommendations can be improved in order to ensure that
recommendations are achieved.
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Further mammographic views: the importance of
getting it right
S Dyson, V Milnes, V Phillips
King’s College Hospital, London, UK
Breast Cancer Research 2006, 8(Suppl 1):P53 (doi: 10.1186/bcr1468)
The accurate diagnosis of breast pathology through mammography can
be enhanced by the judicious use of ‘additional views’ [1,2]. When
carefully applied, these techniques can give definitive answers to
problems indicated on the original films [3]. However, when seeking
extra information it is critical that the correct techniques are applied. If
additional views are taken incorrectly or inaccurately, they can produce
misleading results or false-negative findings. Therefore, our aim in this
poster is to delineate proper applications and to demonstrate — with
the help of case studies — just when and how the taking of additional
views can prove to be a valuable tool. Equally, we show that their
inappropriate use can disguise real pathologies that are intimated on
the original films.
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To assess the clinical usefulness of radio-opaque
marker insertion into malignant breast tumours in
patients undergoing neo-adjuvant chemotherapy
prior to consideration of breast-conserving surgery
SE Evans, RA Crichton
Leighton Hospital, Crewe, UK
Breast Cancer Research 2006, 8(Suppl 1):P54 (doi: 10.1186/bcr1469)
Introduction The study looks at our experience in the first 29 patients
who were referred for marker insertion.
Method The markers were all placed by a radiologist under ultrasound
guidance into the central area of the tumour. The technique is
described.
Results Of the 26 patients who had a successful marker placement,
23 went on to have a good response to chemotherapy. In 15 of these
the tumour was no longer clinically palpable. These patients underwent
standard wire localisation with the hook of the wire placed into the
‘tumour bed’ using either stereotactic mammographic guidance
focusing on the implanted marker (11 patients) or using ultrasound
guidance if the tumour was still visible on ultrasound (four patients).
This enabled the surgeon to perform a wide local excision centred on
the ‘marked’ tumour bed even though it was no longer palpable.
Conclusion  We conclude that the insertion of the radio-opaque
markers into breast tumours is a useful aid to guide breast-conserving
surgery following neo-adjuvant chemotherapy. These initial results
require validation by larger scale studies.
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Education within the workplace: an overview — has
the emphasis on education devalued the importance
of experience?
SJ Ferguson, PB Moffat
Leeds Wakefield Breast Screening Unit, Leeds, UK
Breast Cancer Research 2006, 8(Suppl 1):P55 (doi: 10.1186/bcr1470)
Background Radiographers have been encouraged to perform
extended roles, blurring out traditional boundaries that had previously
existed. Meeting the current demands within the clinical environment
has coincided with dramatic changes in the provision of professional
education. Qualifications gained at the beginning of a radiographer’s
career provide us only with an initiation period now superceded by the
importance of obtaining advanced skills and knowledge.
Aim To assess the importance and value of education within the
workplace and whether this undervalued the importance of experience.
Method Information was assimilated with the distribution of 120
questionnaires to the Breast Screening Units throughout Humberside/
Yorkshire regions relating to postgraduate education within the
departments covering all mammographers. The results were completed
when all units were undergoing assimilation onto the new banding
procedures.
Conclusion Preliminary results indicate that people felt that, in order
for career progression to take place, radiographers had to extend their
role by entering into some sort of academic framework. The
undertaking of academic qualifications on the whole had proven to be a
positive experience. The Agenda for Change (HMSO, 1999) tried to
address the previous absence of National Guidelines that had hindered
the innovative role of radiographers and rewarding them for the job that
they do. However, it was felt that experience had not been recognized
and correlated to radiographers feeling a low perceived status within
the department.
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Breast ultrasound training scheme
AG Gale, S Chambers, HJ Scott
Loughborough University, Loughborough, UK
Breast Cancer Research 2006, 8(Suppl 1):P56 (doi: 10.1186/bcr1471)
Ultrasonography is a common follow-up procedure in breast screening
to help elucidate the nature of potential abnormalities. Due to the
inherent properties of the imaging modality, these images are of fairly
low resolution, as compared with mammography, and therefore pose a
different interpretation problem for the radiologist or imaging specialist.
We describe the steps involved in the development of a PC-based
training scheme for improving the interpretation of ultrasound images.
Using the existing current literature, ultrasound image features were
identified. The key features and the reported difficulty that individuals
had in identifying these were then logged. The construction of an
image database was then undertaken with the aim of amassing both
static images and video clips of imagery that posed particular inter-
pretative challenges. Various optional interfaces that allow participants
to make and record decisions are currently being assessed. Once
complete, the system will be fully trialled and then will be made
available freely available to UK screening personnel.
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Digital mammography: the human factors implications
C Brace1, AG Gale1, M Wallis2
1Applied Vision Research Centre, Loughborough, UK; 2Coventry and
Warwickshire Hospital Breast Screening Unit, Coventry, UK
Breast Cancer Research 2006, 8(Suppl 1):P57 (doi: 10.1186/bcr1472)
A change is underway, with conventional film-screen mammography being
surpassed by the implementation of digital mammography and the
associated soft-copy digital film reporting. However, there is an allied
period of changeover with implementation that requires careful
consideration to ensure optimal performance and efficiency of work tasks.
To examine the human factors implications, a combination of
techniques (expert walkthroughs, verbal protocol analysis, workstation
assessment) was applied to examine existing working practices during
the implementation of digital mammography film reading. Radiologists
and advanced practitioners within a UK NHS Breast Screening Unit
participated to enable a thorough understanding to be gained of
strategies adopted when using: routine conventional roller viewing of
analogue (film) cases with analogue priors; routine soft-copy reporting
with full-field digital mammography (FFDM) priors; trial FFDM with
analogue priors viewed on a multiviewer; and trial FFDM with digitised
analogue cases viewed digitally.
A variety of changes in working practices were recognised to have
occurred with digital implementation. There was an impact upon
performance and efficiency of digital soft-copy reporting when viewing
analogue priors. Subsequent recommendations for workstation design,
working practices and training were produced to assist in improved
implementation of digital processes in mammography.
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Mammography soft-copy reading: to digitise priors or
not, that is the question
L Galloway
Breast Screen Victoria, Melbourne, Australia
Breast Cancer Research 2006, 8(Suppl 1):P58 (doi: 10.1186/bcr1473)
Evidence is accumulating on the use of digital mammography. But
there is relatively little published guidance on how to manage hard-
copy film-screen prior images in a soft-copy reporting environment. For
a population screening program, one pressing question is ‘to digitise
priors, or not?’.
The BreastScreen Victoria programme screens 200,000 women each
year, with two-view mammography at 2-yearly intervals. Many women
have completed their fifth round of screening. Ten million films are
archived. Existing standards require independent double-blind reporting
comparing prior and current images. As digital is introduced, each
reader needs to compare soft-copy images with hard-copy priors. How
do we merge the two different reading worlds, analogue and digital, or
indeed should we even attempt this?
Possibilities include digitising; using a special multi-viewer; using a dental
viewing box; or loading an analogue multi-viewer alongside the soft-copy
5MP monitors. Factors specific to digitising include the following: Is it
possible to digitise in such numbers? Is it too time consuming or too
expensive? What resolution should be used to digitise? Is the quality of
digitised priors sufficient for comparative review? This poster traces the
decision-making process to digitise prior images in the context of a digital
mammography pilot within BreastScreen Victoria.
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Digital on the road down-under
L Galloway1, G Raw2, S Macaulay1
1BreastScreen Victoria, Melbourne, Australia; 2BreastScreen
Tasmania, Hobart, Australia
Breast Cancer Research 2006, 8(Suppl 1):P59 (doi: 10.1186/bcr1474)
Digital mammography is being introduced worldwide in fixed-site
screening and diagnostic clinics. BreastScreen Australia services use
mobile vans to deliver screening to women in rural and remote
Australia. BreastScreen Victoria (BSV) has installed a Computerised
Radiology (CR) unit on a mobile van, while BreastScreen Tasmania
(BST) has installed a Direct Radiology (DR) system.
Digital systems offer benefits over analogue systems on mobile vans.
One benefit is image processing without chemicals. Currently, radio-
graphers on BSV and BST mobile vans work ‘blind’. They cannot
process and view images due to difficulties in maintaining processor
quality when vans are moving. Unprocessed films are couriered across
the country and women must return if repeat views are required. Digital
imaging overcomes this limitation as radiographers can view their
images instantaneously.
Available online http://breast-cancer-research.com/supplements/8/S1
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problems. Harsh Australian conditions affect system reliability.
Movement along rural country roads and temperature fluctuations from
–5°C to over 40°C can affect the stability of detectors and lasers.
Limited broadband infrastructure poses difficulties in meeting IT and
communication network requirements.
This poster reports on implementation challenges and compares the
strengths and weaknesses of using CR and DR in a digital mobile
environment in Australia.
60
Targeting Asian women results in greater uptake for
breast screening
P Gillespie
Jarvis National Breast Screening, Training & Diagnostic Centre,
Guildford, UK
Breast Cancer Research 2006, 8(Suppl 1):P60 (doi: 10.1186/bcr1475)
Breast cancer is one of the most common cancers among all women in
the United Kingdom. The 2001 uptake rate for invitations to attend
screening at a breast screening centre was observed to be low (53%)
for GP practices with a high population of Asian women.
The breast screening health promotion team plus an interpreter, who
was well known in the community, held a roadshow in a shopping
centre in May 2004. This brought breast screening issues to the
attention of the target group with a wide range of linguistic abilities. It
was found that both Asian men and women responded positively to
literature and personal discussion in their own language.
In November 2004 the GP practices with a high proportion of
registered Asian women were invited for breast screening, and the
uptake was 80% in the 50–70 years age range. This shows that the
targeted health promotion enabled the women to make informed
choices about accepting the breast screening invitation, despite the
obvious barriers.
Questions for future research are: Will the acceptance rate be
maintained without further targeting in 2007 when the women are re-
invited for screening? Should a culturally based information programme
be implemented to develop cost-effective breast screening for ethnic
minorities?
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Addressing pain on compression: women and
radiographers working together
L Galloway1, M Conneely2, C Gibbins2, P Hartney2, S Hayes2,
A Maloney1, H Varney1, Radiography ‘Q’ Group2
1Bendigo Regional BreastScreen, Bendigo, Australia; 2BreastScreen
Victoria, Melbourne, Australia
Breast Cancer Research 2006, 8(Suppl 1):P61 (doi: 10.1186/bcr1476)
Pain on compression is a major source of complaints to screening
programmes. Fear of pain may affect women’s participation and thus
limit a programme’s potential to reduce mortality. This poster describes
a quality improvement project on pain in which radiographers and
women worked in partnership.
BreastScreen Victoria screens over 200,000 women each year. Our
Screening and Assessment Services audit complaints and provide a
forum for consumer advisory groups to discuss these complaints and
offer recommendations for quality improvement. A Radiography ‘Q’
Group is responsible for monitoring and reviewing state-wide service
quality and safety.
A strategy to manage pain on compression was developed at
BreastScreen Victoria’s Bendigo service. The service monitored
complaints about pain, consulted its Consumer Advisory Group, and
devised an information-based strategy that successfully reduced
complaints and improved women’s experience. The Radiography Q
Group has further developed the strategy and is currently overseeing
its implementation at all screening sites.
The success of the Pain on Compression project confirms the value of
a radiographer-specific quality group working with women to achieve
improvements in our screening programme.
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Avoiding unnecessary sentinel node biopsy
JS Jeffree, Z Saad, MS Bashir
Hope Hospital, Salford, UK
Breast Cancer Research 2006, 8(Suppl 1):P62 (doi: 10.1186/bcr1477)
Sentinel node biopsy is a surgical technique that identifies the first
axillary node to which a breast tumour drains directly. If positive, node
clearance is performed as a secondary procedure. Prior knowledge of
metastatic lymphadenopathy allows primary axillary node clearance,
avoiding the associated financial and psychological costs of two
surgical procedures.
A retrospective study of primary breast cancer patients treated in Hope
Hospital Breast Unit between April 2004 and March 2005 was
performed to assess the efficacy of axillary ultrasound and clinical
examination in assessing axillary node status.
Of 96 patients with 97 cancers identified, 69 had ipsilateral axillary
ultrasound. Eight patients were excluded because axillary surgery was
not performed.
Table 1 (abstract 62)
Histology positive?
Yes No
Palpable nodes? (six not recorded)
Yes 13 2
No 13 27
Ultrasound positive?
Yes 21 4
No 8 28
Either nodes palpable or ultrasound positive?
Yes 23 5
No 6 27
The sensitivity of axillary palpation alone in detecting metastatic nodes
was 50%, the specificity was 93%, the PPV was 87% and the NPV
was 68%. For axillary ultrasound alone, the sensitivity was 72%, the
specificity was 88%, the PPV was 84% and the NPV was 78%. The
combination of clinical and ultrasound examination predicted meta-
stases with sensitivity 79%, specificity 84%, PPV 82% and NPV 82%.
Combining clinical examination and ultrasound missed only 10% of
metastatic nodes. In another 8% of cases, ultrasound or axillary
palpation was falsely positive and FNA of these nodes could have
reduced the risk.
We recommend that routine axillary ultrasound with FNA is adopted
prior to embarking on sentinel node biopsy.
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Investigation and analysis of the benign surgical biopsy
rate in the prevalent screening round (2001–2002)
JM Leadbetter1, CH Beattie1, P Hogg2
1Breast Unit, Linda McCartney Centre, Royal Liverpool Hospital, Liverpool,
UK; 2Directorate of Radiography, Salford University, Salford, UK
Breast Cancer Research 2006, 8(Suppl 1):P63 (doi: 10.1186/bcr1478)
Introduction Quality assurance is a fundamental part of the National
Health Service Breast Screening Programme. National quality
standards are in place for all stages of screening and for all
professionals involved. The performance of individual units is monitored
to ensure all women have access to an excellent service.
Aim This project aims to demonstrate how the Liverpool Breast Unit
addressed failure to meet the national quality standard for the benign
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standard was of concern because benign biopsies are associated with
high healthcare costs and patient anxiety.
Method  A retrospective review of the records of patients who had
undergone benign biopsy (2001–2002) was conducted to establish
reasons for surgical referral and suggest corrective measures to enable
the unit to meet the standard in the future.
Results The review concluded that that the benign biopsy rate achieved
(Fig. 1) did not reflect the performance of the unit and recommended an
action plan to improve the standard. This plan was implemented, and as
a result the standard has improved in subsequent years.
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Imaging methods in differentiation between
inflammatory breast cancer and post-treatment changes
V Lehotska, S Ivanova
2nd Radiology Clinic, Medical Faculty, Cohenius University and 
St Elisabeth Oncology Institute, Bratislava, Slovakia
Breast Cancer Research 2006, 8(Suppl 1):P64 (doi: 10.1186/bcr1479)
The aim of the study is assessment of the role of non-invasive imaging
methods such as mammography, ultrasound and magnetic resonance
imaging in the diagnosis of inflammatory breast diseases. The study is
mainly focused on the pitfalls in the diagnosis of inflammatory breast
cancer and differentiation against another inflammatory lesions,
including breast tissue changes after radiation therapy. Inflammatory
breast cancer has a mammographic pattern of inflammatory changes,
such as skin thickening and stromal coarsening and/or diffusely
increased breast density with or without an associated mass and/or
malignant-type microcalcifications. Ultrasound is helpful not only in
depiction of masses masked by the edema pattern, but also in the
demonstration of skin and pectoral muscle invasion and axillary
involvement. Magnetic resonance imaging is used to differentiate
residual tumor from post-treatment fibrosis and glandular tissue.
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Knowledge about breast cancer and attitudes to
seeking help with breast cancer symptoms among
older women
L Linsell, M Cochrane, C Burgess, A Ramirez
Cancer Research UK London Psychosocial Group, Institute of
Psychiatry/Kings College, London, UK
Breast Cancer Research 2006, 8(Suppl 1):P65 (doi: 10.1186/bcr1480)
Older age is a risk factor for developing breast cancer and delayed
presentation; however, routine breast screening on the NHSBSP ends at
age 70. The aim of this study was to examine how well-equipped older
women are to seek help following symptom discovery after their final
routine mammogram. We conducted a questionnaire survey among a
national sample of 850 women aged 67–73 years (response rate 84%).
Fifty per cent of women underestimated their lifetime risk of developing
breast cancer as less than 1 in 100, and 75% believed their age
decreased the likelihood of them developing breast cancer or made no
difference. Identification of 11 possible breast cancer symptoms varied
from 93% of women for a breast lump to 14% for nipple rash. Women
with no formal education knew fewer breast cancer symptoms than
those with at least O-levels (P < 0.001). Poorer knowledge about
breast cancer symptoms was associated with less confidence in being
able to detect a breast change (P < 0.001) and with decreased
intention to seek help in the event of symptom discovery (P = 0.02).
Increasing knowledge of breast cancer and the confidence to detect breast
cancer symptoms as women leave the routine protection of the NHSBSP
may reduce delays in presentation by older women with breast cancer.
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An aid to the viewing and reporting of the
mammograms of the augmented breast
HJ Miller, J Diffy, DS Enion
East Lancs Breast Screening Service, Accrington, UK
Breast Cancer Research 2006, 8(Suppl 1):P66 (doi: 10.1186/bcr1481)
We present a tool to aid in the visualisation of the breast tissue in
women who have breast implants.
The tool presented is easy to use and cheap to make. A selection of
different sizes and shapes of mask is used to correspond to the various
shapes and sizes of implant. The tool may be customised to a suit a
specific implant.
The tool is placed directly over the implant to mask the light transmitted
through it. Subjectively, this gave a great improvement in the quality of
the image of the breast tissue demonstrated.
A study was undertaken to accurately measure the luminance (cdm2) in
all areas of the breast demonstrated on the mammograms. A wide
range of readings were achieved throughout the breast and varied
considerably as we measured through glandular and fibrous tissue as
well as through adipose tissue and skin.
We conclude that the relative brightness of the visualised breast tissue
increases by a factor of 10,000 with the use of the tool to mask the implant.
Mammographers and film readers have found this tool a useful aid to the
viewing and accurate reporting of mammograms of the augmented breast.
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Comparison of outcome data for screen-detected and
symptomatic breast cancers diagnosed in the West
Midlands region in 2002
C Lagord1, O Kearins1, G Lawrence1, H Bishop2, I Monypenny3, 
T Bates4
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Annually since 1996, screen-detected breast cancers within the NHS
Breast Screening Programme have been audited at a national level.
Available online http://breast-cancer-research.com/supplements/8/S1
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Figure 1 (abstract 63)The Breast Cancer Clinical Outcome Measures (BCCOM) Project
aims to conduct a similar audit for symptomatic breast cancers. The
first round of the BCCOM Project audited cancers diagnosed in 2002.
For the West Midlands region, the 949 cases included in the national
audit of screen-detected breast cancers and the 2,504 symptomatic
cases included in the BCCOM Project were compared.
Non-invasive breast cancers formed 5% of the symptomatic cohort,
compared with 23% for screening. Symptomatic cancers were larger
(mean size 24.5 mm vs 16.6 mm) and more likely to be node-positive
(42.7% vs 27.5%). Forty per cent of the symptomatic breast cancers
had mastectomy compared with 27% of the screen-detected cohort,
and small (diameter <15 mm) invasive symptomatic cancers were more
likely to receive a mastectomy than comparable screening cases (31%
vs 16%).
For invasive cancers with a known Nottingham Prognostic Index score,
20% of the symptomatic cancers fell into the excellent and good
prognostic groups compared with 58% of screen-detected cancers.
For women aged under 65, the proportion with screen-detected
cancers receiving chemotherapy was lower than those with sympto-
matic cancer (20% vs 36%). Screening cases were also less likely to
receive radiotherapy (48% vs 63%).
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Breast Cancer Clinical Outcome Measures Project:
national results from year 1
C Lagord1, O Kearins1, G Lawrence1, H Bishop2, I Monypenny3, 
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1West Midlands Cancer Intelligence Unit, Birmingham, UK; 2Royal
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The Breast Cancer Clinical Outcome Measures (BCCOM) Project
aims to audit the clinical management of symptomatic breast cancers in
the United Kingdom. The information needed for the audit is obtained
by tapping into existing sources such as the data currently collected by
cancer registries and individual clinicians.
In collaboration with the UK cancer registries and 191 breast surgeons
registered with the UK Association of Breast Surgery at BASO, data
for a total of 16,407 breast cancers diagnosed in 2002 were collected.
In the data for year 1 of the BCCOM Project, the proportion of patients
not receiving surgery increased from 6% in those aged 50–64 to 41%
in those aged 80 and above. Overall, 48% of the surgically treated
cases received a mastectomy, but mastectomy rates varied between
surgeons from 19% to 92%. The proportion of patients treated with
radiotherapy and chemotherapy fell sharply with age, while the
proportion treated with hormone therapy increased with age. The
proportion of cancers with known nodal status decreased from 68% in
patients aged 50–64 to 30% in those aged 80 and above. Nodal
positivity varied between 12% for small cancers (diameter <10 mm) to
81% for large cancers (diameter >50 mm).
Year 2 of the BCCOM Project, which will examine clinical outcomes for
symptomatic breast cancers diagnosed in 2003, was launched in
January 2006.
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Breast lesion localisation wires: a change in practice
AJ Pavis, A Murphy
Breast Imaging Unit, York Hospital, York, UK
Breast Cancer Research 2006, 8(Suppl 1):P69 (doi: 10.1186/bcr1484)
At York Hospital, breast lesion localisation wires have routinely been
inserted on the same day as the surgical operation. In August 2003, we
offered an additional service where localisation wire insertion was
undertaken on the day before surgery. This change in practice was
necessary in order that the guidelines for patient waiting times be met.
An audit took place to assess the impact of increasing the length of
time prior to surgery at which a breast lesion localisation wire is
positioned. The audit compared information about patients who had
surgery on the day of the localisation wire insertion with patients who
had surgery on the day after.
The results of the audit suggest that, in our unit, the placement of a
breast lesion localisation wire the day before surgery is a useful
technique without any complications.
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Interpretation of mammographic breast
microcalcification: interobserver variability between
radiologists and mammographers and analysis of
best mammographic predictors of histopathological
outcomes
LS Naidu, A Kukula, P Sentance, B Baxter, R Jones
United Hospitals of Lincolnshire, Pilgrim Hospital, Boston, UK
Breast Cancer Research 2006, 8(Suppl 1):P70 (doi: 10.1186/bcr1485)
Purpose To evaluate the interobserver variability among readers,
thereby assessing the performance of radiologists versus radio-
graphers in differentiating mammographic breast microcalcification.
We also analyse the best mammographic predictors of histopatho-
logical outcome.
Materials and methods One hundred patients were randomly
selected with microcalcification (MC) on their screening mammograms
who underwent stereotactic core biopsy at our institution between
August 2002 and August 2004. All the mammograms were retro-
spectively read by five readers independently. Each observer noted the
various features and final analysis category for all MCs. Interobserver
variabilities were calculated using Cohen’s kappa statistics, Kilem
Gwet’s agreement coefficient 1 and the interclass agreement
coefficient. The performance of radiologists and mammographers were
determined using a logistic regression model. Overall best predictors
of histopathology outcomes were also determined.
Results Interobserver agreement was moderate to good for
distribution, moderate for the shape, moderate for final analysis
category, poor for morphology, poor for variation in density of MC and
poor for category on more MC on magnification. There is a significant
difference in determining the benign nature of MC and the overall
differentiation of MC between radiologists and mammographers
favouring radiologists. There is no significant difference between them
in determining malignant MC. The best predictors of histopathology
were the morphology (P  < 0.0001), distribution (P  < 0.0042) and
number of MCs (P < 0.013).
Conclusion There is moderate interobserver variability in assessment
of the final analysis category (benign vs malignant). The radiologists are
significantly better than mammographers in determining the benign
nature and overall assessment but not significantly better at
determining definite malignancy. The morphology, distribution and
number of MCs are the best predictors of histopathological outcome.
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‘What’s the point of it?’: radiographers, women with
disability and mammography screening
AE Poulos, G Llewellyn, S Balandin, A Dew, L Dark, L McCarthy
University of Sydney, Australia
Breast Cancer Research 2006, 8(Suppl 1):P71 (doi: 10.1186/bcr1486)
Women with disability are underutilising mammography screening,
which is contributing to a higher than expected mortality rate from
breast cancer. Barriers to participation experienced by women with
disability include receiving information about mammography screening,
communication difficulties during the procedure and staff attitudes [1].
A large study funded by the Australian National Breast Cancer
Foundation investigated these barriers and determined solutions. One
part of this study is reported here.
Radiographers employed by BreastScreen NSW, Australia, participated
in focus groups to investigate their attitudes and perceptions of
mammography screening for women with disability.
Breast Cancer Research    Vol 8 Suppl 1 Symposium Mammographicum 2006
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(page number not for citation purposes)Radiographers expressed many concerns about mammography
screening for these women. Issues raised included the necessity of
mammography screening, legal consent, the role of carers and the
need for education of BreastScreen staff. Wheelchairs, which
prevented the mammography equipment from being positioned
appropriately, were identified as a major barrier to producing optimally
diagnostic mammography films. Importantly, radiographers indicated
that the provision of relevant information in appropriate formats for
these women would greatly improve the potential for a successful
mammography completion.
Reference
1. Poulos A, Llewellyn G, Balandin S, Dew A: Women with cerebral
palsy and breast cancer screening by mammography. Arch
Phys Med Rehab 2006, 87:304-307.
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‘I want to go home’: women with disability and the
mammography procedure
AE Poulos, G Llewellyn, S Balandin, A Dew, L Dark, L McCarthy
University of Sydney, Australia
Breast Cancer Research 2006, 8(Suppl 1):P72 (doi: 10.1186/bcr1487)
Women with disability are underutilising mammography screening,
which is contributing to a higher than expected mortality rate from breast
cancer. Barriers to successful mammography screening include the
mammography procedure, which has been identified as problematic for
these women [1]. A large study funded by the Australian National Breast
Cancer Foundation investigated these barriers and determined
solutions. One part of this study is reported here.
In situ analysis was used to identify barriers as they occur when
women with disability have a mammogram. Under scrutiny was the
interaction between the woman, the radiographer and the
mammography equipment.
The analysis identified the need for assistive technologies such as
hoists, extra personnel and extra time and space. For some women a
successful completion was not possible. A dedicated centre or mobile
van to provide the assistance required would greatly facilitate
successful completions. Most importantly, a decision tool that would
predict successful completions would avoid the trauma for women
needlessly undergoing the mammography procedure. These women
could then be offered alternative strategies.
Reference
1. Poulos A, Llewellyn G, Balandin S, Dew A: Women with cerebral
palsy and breast cancer screening by mammography. Arch
Phys Med Rehab 2006, 87:304-307.
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Audit to assess the quality of mammograms in a
symptomatic service providing family history screening
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C Record1
1Stoke Mandeville Hospital, Aylesbury, UK; 2Aylesbury Breast
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Breast Cancer Research 2006, 8(Suppl 1):P73 (doi: 10.1186/bcr1488)
Objective To determine whether the standard of mammography in a
district general hospital’s symptomatic service is equivalent to that in
the NHSBSP. NICE guidance recommends that mammography for
women with a family history of breast cancer should be to NHSBSP
standards and should be audited [1]. The quality of mammograms is an
important component of a mammography screening service.
The NHSBSP’s minimum standard for mammography is that <3% of
examinations should be repeated, with a target of 2% [2].
Methodology Two hundred consecutive film sets were assessed by
symptomatic mammographers and 22% were reassessed by a
screening mammographer, using Perfect, Good, Moderate, Inadequate
(PGMI) criteria [2].
Results Seventy-three per cent of films scored by the symptomatic
radiographers were assessed as ‘good’ or ‘perfect’, 3% were technically
inadequate. The BSU mammographer scored fewer films as ‘good’ or
‘perfect’. Mammograms on women up to the age of 70 were assessed
with a reject rate of 1%, with 87% of films assessed as ‘good’ or
‘perfect’.
Conclusion  This audit has shown that the symptomatic mammo-
graphers produce films to a standard sufficient to provide family history
mammography.
References
1. Familial Breast Cancer. NICE Clinical Guidelines CGO14; June
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2. Quality Assurance Guidelines for Radiographers. NHSBSP Publi-
cation No. 30; March 2000.
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Are there lessons to learn from review of 
false-negative assessment interval cancers?
N Sharma, G Smith, J Liston
Leeds/Wakefield NHS Breast Screening Service, Leeds, UK
Breast Cancer Research 2006, 8(Suppl 1):P74 (doi: 10.1186/bcr1489)
Purpose To maximise the early detection of breast cancer by
optimising the assessment process.
Materials and methods The notes and imaging of women who were
screened and assessed between April 1995 and March 2004 but who
subsequently developed breast cancer prior to their next routine screen
were retrospectively reviewed. A total of 11,341 women were
assessed during this time period. Twenty false-negative assessment
cases were identified but three were excluded as the abnormality
assessed was located at a different site in the breast (one case) or in
the contralateral breast (two cases). The remaining 17 cases were
examined and the reasons for failure of the assessment process
postulated.
Results Six cases were recalled for assessment of stromal deformity,
four cases for calcification and seven cases for asymmetry. Some
mammographic signs were misinterpreted, especially cases of
distortion where the focal compression view was falsely reassuring.
Some cancers may have been detected earlier if a core biopsy had
been included in the assessment process. However, some cases were
challenging and the diagnosis was not made despite undertaking full
triple assessment.
Conclusion Overall, the proportion of women undergoing false-
negative assessment in this study was very low. Strategies to further
improve the accuracy of screening assessment are suggested.
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Ultrasound breast imaging versus pathology;
correlation of reported benign ultrasound scans with
subsequent biopsy
M Sinclair
Kingston University & St George’s Hospital University of London,
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Breast Cancer Research 2006, 8(Suppl 1):P75 (doi: 10.1186/bcr1490)
In the absence of any suspicious mammographic findings, lesions that
appear benign with ultrasound yield benign pathology [1-5].
This retrospective study investigated the outcome of needle biopsy of
ultrasonically benign appearing masses. The sample group included
patients attending a symptomatic breast clinic at a busy London
teaching hospital, from 2000 to 2003. Eight hundred and seventy-two
cases fulfilled the following criteria: a solid mass graded U2, and an
absence of any suspicious mammographic findings (M1/M2), if
mammogram performed. A definitive pathological result had been
obtained from fine needle aspiration cytology (FNA) or wide-bore
needle biopsy (WBN). Cases also had a follow-up period of 18 months
following FNA or WBN; 872 cases fulfilled this inclusion criteria. The
results demonstrated 865 cases (99.2%) were true negatives and
seven cases (0.8%) were false negatives.
This revealed that there is a strong positive correlation with benign
appearing breast masses seen with ultrasound and their respective
Available online http://breast-cancer-research.com/supplements/8/S1
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(page number not for citation purposes)pathological findings. The recommendations are to continue with
further study to include all cases (not just benign). Also to develop a
standardised reporting system, particularly for the training of junior staff
members.
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Pharmacokinetic, shape and texture parameters:
comparison with breast tumour grade
M Sreenivas1, P Gibbs2, LW Turnbull2
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Introduction The histological tumour grade is one of the most
important biological prognostic factors in breast cancer. The aim of our
study was to compare pharmacokinetic, shape and texture parameters
from breast DCE-MRI with the breast tumour grade.
Methods Two hundred and two malignant breast lesions for which the
histological grade was available were scanned on a 1.5 T scanner. The
2D T1W FSPGR dynamic scans were followed by 3D T1W FSPGR
fat-saturated post-contrast scans. Various pharmacokinetic [1], texture
[2] and shape [3] parameters were calculated and the significance of
each of the parameters for each of the three tumour grades was
assessed.
Results The 202 lesions were 36 grade I, 110 grade II and 56 grade III
malignant lesions. Pharmacokinetic parameter Ktrans (P = 0.025) and
shape parameter phi1 (P = 0.039) were significantly different between
the grades of tumours. However, there was significant overlap between
the tumour grades for both of these parameters. None of the texture
parameters were significantly different between the tumour grades.
Conclusions Although Ktrans and phi1 were significantly different
between breast tumour grades, none of the pharmacokinetic, shape
and texture parameters can be reliably used to differentiate various
tumour grades at the present time.
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Usefulness of magnetic resonance imaging in benign
and malignant breast lesions: a pictorial review
M Stahnke, R Ramachandra
Breast Unit, Coventry and Warwickshire Hospital, Coventry, UK
Breast Cancer Research 2006, 8(Suppl 1):P77 (doi: 10.1186/bcr1492)
Magnetic resonance imaging (MRI) can play a role in the early
detection of breast cancer or recurrent disease in cases when
mammograms are not helpful. It is reported that malignant lesions
enhance significantly following contrast injection while benign lesions
show little or no enhancement. MRI has been shown to detect small
breast lesions with sensitivity greater than mammography and can
successfully image the dense young breast.
We would like to highlight a number of interesting cases of benign and
malignant breast lesions detected with MRI in our tertiary referral centre,
including intracapsular and extracapsular implant rupture, silicon leak,
fibroadenoma versus fibrosarcoma and a case of extensive fat necrosis.
We would also like to demonstrate the usefulness of MRI in the
preoperative assessment of patients with multifocal lobular and ductal
carcinoma as well as postoperative surgical change and axillary node
involvement. In all our cases, MRI was a valuable adjunct in the
diagnoses and subsequent management of patients with breast disease.
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Columnar cell change on core biopsy: radiological
features and outcome
VR Stewart, A Ljutikov, N Dutt, N Akbar, R Wasan, D Evans, 
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Introduction  Columnar cell change (CCC) is diagnosed on core
biopsies performed for indeterminate microcalcification. The diagnosis
of columnar cell change on stereotactic core biopsy presents a
management difficulty because of uncertainty regarding the patho-
logical and clinical significance of such lesions.
Aim The aim of this study is to describe the radiological features of
lesions in which CCC is seen on core biopsy and to review the outcome.
Method Mammograms of 33 cases with established CCC on core
biopsy were reviewed and the radiological features, follow-up imaging
and surgical excision histology (if performed) were collated.
Results Thirty-three cases were reviewed. In 10/33 cases an
associated benign histology was present. Twenty-three out of 33
patients demonstrated CCC alone on core biopsy, 14 with atypia and
nine without. In 23/23 patients (100%), the radiological feature was
indeterminate microcalcification (M3).
Nine patients with CCC have proceeded to surgical excision to date.
The histology was upgraded to DCIS in two patients. Further excision
data and follow-up of patients with CCC who did not undergo surgery
will be presented.
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Use of health promotion to improve uptake in breast
screening in Northamptonshire
R True, G Baxter, C Pal
The Forrest Centre, Northampton General Hospital NHS Trust,
Northampton, UK
Breast Cancer Research 2006, 8(Suppl 1):P79 (doi: 10.1186/bcr1494)
Objectives A reduction in mortality in breast cancer is the aim of the
NHSBSP, with the uptake rate being an important factor. The quality
standard is to achieve an uptake greater than 80%.
Northampton Breast Screening is a small unit covering Northampton
and South Northamptonshire, with a wide social range.
With the age extension, 44,000 women will be invited for screening over
a 34-month period to May 2006. Attendance rates for breast screening
are a factor affecting cancer detection rates. Uptake for the previous
round was 78.8%, ranging from 68.9% to 82.2% at practice level.
Aim The aim of the Forrest Centre is to improve the uptake of women
invited for breast screening in Northamptonshire by health promotion
and targeting of low-uptake GP practices.
Method The Forrest Centre has a radiographer dedicated to health
promotion, working with the programme manager and primary care
trust (PCT). GP practices were targeted by educating staff, poster
displays and computerised flagging of those that did not attend. A
letter written by the GP endorsing breast screening was included with
Breast Cancer Research    Vol 8 Suppl 1 Symposium Mammographicum 2006
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surgeries in socially deprived areas.
Results and conclusion The uptake rate has risen from 78.8% to the
quality assurance standard of 80% achieved through health promotion,
particularly the letter endorsing screening.
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The NHSBSP age extension: completed first-round
statistics from Southern Derbyshire — why it works
for us!
AE Turnbull, M Bagnall, B Young, J Holmes
Breast Unit, Derby, UK
Breast Cancer Research 2006, 8(Suppl 1):P80 (doi: 10.1186/bcr1495)
Southern Derby Breast Screening Service began inviting women up to
the age of 70 years at the beginning of January 2003, and completed
the first full round of screening for women aged 65–70 years on
schedule in December 2005.
Data are presented for these women, in comparison with the 50–64
age group, and we describe briefly the simple but effective ways of
working with administrative and radiographic teams to cope with the
additional workload. For example, extending the skill mix, calling women
numerically rather than alphabetically, introducing new mobile sites at
central locations to encourage attendance, ensuring sufficient
assessment slots and pre-allocating assessment appointments for
smooth running clinics. The screening service has maintained all
targets during this period.
The statistics show that women aged 65–70 years in Southern
Derbyshire attend as well as, or better than, women aged 50–64 years.
There is a similar overall recall rate, but with a high specificity for
cancer. An excess of invasive cancers were detected for what is in
effect a prevalent round. We are also finding that women aged >70
years are self-referring in increasing numbers, from 264 in 1999 to 503
in 2005.
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Breast screening histories: variation with time and
impact on 10-year survival
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Every case of primary breast cancer diagnosed in the West Midlands
since screening began until 31 March 2001 was assigned a screening
status based on the woman’s screening history. Eligible cases were
identified from the West Midlands Cancer Intelligence Unit’s cancer
registration database. Screen-detected (SD) tumours were identified
through regional breast screening units. The remaining tumours were
allocated to one of eight screening status categories.
A total 14,625 breast cancers were classified. The number of SD,
interval cancers (IC), and cancers in lapsed attenders increased over
time. There was a decrease over time in the number of cancers
diagnosed in women before invitation and in nonattenders. IC rates
were lower 24–36 months from screening to diagnosis compared with
12–24 months. Around one-third of cancers in lapsed attenders and
nonattenders were diagnosed within 8 months of their last invitation,
suggesting that they may have been screening provoked.
There was a significant difference in the 10-year relative survival rates
for attenders (SD, IC, lapsed attenders and nonattenders; 85.2% and
53.9%, respectively; RR = 1.58; P < 0.00001). Women with IC had
survival rates above those of nonattenders, highlighting the benefits of
screening.
Table 1 (abstract 81)
10-year relative 
Screening status  Proportion (%) survival rate (%)
Screen-detected (SD) tumours 43 91.99
Interval cancer (IC) 27 75.68
Diagnosed before invitation 13 68.79
Lapsed attender 3 72.56
Nonattender 10 53.93
Unknown to NHSBSP 2 39.26
Reference
1. J Med Screening 2005, 12:179-184.
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Audit of ultrasound-guided breast biopsy/fine needle
aspiration, in response to increasing demand on
service provision
A Wharton, L Khoo
St George’s Hospital, London, UK
Breast Cancer Research 2006, 8(Suppl 1):P82 (doi: 10.1186/bcr1497)
Aims To evaluate usage of ultrasound biopsy appointments. To elicit
factors that might influence numbers referred for biopsy.
Methods  A retrospective review of all patients attending for breast
biopsy/FNA over a 6-month period. Ultrasounds were graded U2–U5
and were compared with pathology/cytology outcomes. The positive
predictive value (PPV) for the ultrasound grade was calculated. Other
factors such as age, specific ultrasound features, correlation with
mammographic findings and size were obtained for U3 lesions.
Results There were 199 biopsy appointments in 179 women aged
21–93 years. Sixteen had no histopathology/cytology — either the
lesion resolved or a simple cyst aspirated. Of the remaining women,
51% were graded U3, 9% U4 and 11% U5. The PPV for U3 lesions
was 13%. U4 and U5 PPVs were 69% and 95%, respectively,
comparable with published standards. Forty-eight cases were U2,
mainly for completion of triple assessment.
Conclusions  U2 and U3 lesions form the majority of the biopsy
workload. The PPV for U3 lesions is lower than the expected standard.
Correlation with additional imaging and demographic factors may allow
for downgrading of some benign lesions previously designated U3,
with concomitant freeing of capacity.
Available online http://breast-cancer-research.com/supplements/8/S1
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Table 1 (abstract P80)
Number  Uptake rate  Referral rate  Number of  Non-invasive  Invasive  Small 
screened (%) (%) women referred cancer/1,000 cancer/1,000 cancer/1,000 Total cancers
2003 4206 85.4 3.04 128 2.14 9.03 4.99 48
2004 3728 85.1 3.62 135 1.61 9.92 4.02 44
2005 4350 79.6 3.03 132 1.84 7.36 4.14 4083
Failsafe batches: are we optimising their effectiveness
for both the screening service and the woman?
ME Wheaton1, S Roath2
1Warwickshire Solihull & Coventry Breast Screening Service,
Coventry, UK; 2Hereford & Worcester Breast Screening Service,
Bromsgrove, UK
Breast Cancer Research 2006, 8(Suppl 1):P83 (doi: 10.1186/bcr1498)
In order that women continue to receive an invitation for screening at 3-
yearly intervals when they move locations around the United Kingdom,
screening services initiate ‘Failsafe’ batches at 3-monthly intervals or less.
Currently there is a variety of practice in the specification of these
failsafe batches within the NHSBSP, and variations in appointment
booking practice associated with these batches.
The National Co-ordinating Group for Administration and IT in Breast
Screening is reviewing these practices with the aim of producing
national guidance on the most effective approach, both in terms of
accessibility and acceptability for the women involved and cost-
effective resource management for the service.
This poster outlines the results of the review and documents the key
points in best practice.
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An audit of women attending for symptomatic recall
following routine NHSBSP screening at the South
West London Breast Screening Service between 1991
and 2004
CM Morris, E Smith, S Davies, LS Wilkinson
South West London Breast Screening Service, London, UK
Breast Cancer Research 2006, 8(Suppl 1):P84 (doi: 10.1186/bcr1499)
NHSBSP guidelines recommend that symptoms or signs reported at the
time of mammographic screening should be evaluated by the film reader
and the woman should be recalled for further assessment if appropriate.
The aim of this audit was to document the clinical features most likely to be
associated with cancer and to clarify our guidelines for symptomatic recall.
We identified 1,075 women with normal screening mammograms who
had breast symptoms or signs recorded at screening and were subse-
quently recalled for assessment between April 1991 and July 2004.
The results showed that cancer was found in 13/1,075 women. Of
these, nine women had a lump (invasive cancers), two women had a skin
dimple (invasive cancers), one woman had an eczematous nipple change
(Paget’s disease) and one woman had a bloody nipple discharge (DCIS).
Our audit shows that the majority of symptomatic recalls did not have
cancer (1,062/1,075), and no cancers were detected in women with
thickening, nodularity, lumpiness, breast pain/odd sensations or
nonblood-stained nipple discharge. More significant symptoms, which
in some cases proved to be indicative of an underlying cancer, were a
lump in the breast or axilla, a skin dimple, an eczematous/weeping
nipple, a bloody nipple discharge and nipple inversion.
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An audit of women attending for technical repeat
mammography at the South West London Breast
Screening Service between 1991 and 2004
CM Morris, LS Wilkinson
South West London Breast Screening Service, London, UK
Breast Cancer Research 2006, 8(Suppl 1):P85 (doi: 10.1186/bcr1500)
NHSBSP guidelines recommend that the number of women
undergoing repeat examinations should be minimised.
When films are scrutinised for possible cancers, the technical quality
should be evaluated and technically inadequate films should be
repeated (technical recall). The purpose of this review was to show
how many cancers were detected following technical recall.
A retrospective audit of cancers detected at technical recall between
January 1991 and March 2004 was performed. During this time
11,149 women were recalled for repeat mammograms. Cancer was
detected in 18 of the women who were assessed following technical
repeat mammography.
The results showed that only 10 women in 13 years had a cancer
detected on the repeat mammogram that was not visible on the initial
screening mammogram.
A further eight cancers were detected because review of the initial
films at the time of the technical repeat showed subtle abnormalities
that had not previously been appreciated.
Our results show that very few additional cancers are detected
following technical repeat mammography despite considerable effort to
achieve optimal imaging.
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Barcode data entry for film reading: information loss
and consequences
S Wilson1, LS Wilkinson2, P Taylor3
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Barcode data entry for screening mammography offers the attractive
possibility of speeding-up a labour-intensive process. Currently,
significant time is spent manipulating paper forms with the additional
potential for error that this incurs. However, the barcode data entry
systems introduced in some centres allow the film reader to enter only
a decision. By contrast, film readers using paper forms frequently
annotate the forms to record additional information.
Concerned by the possible consequences of this information loss, we
conducted an ethnographically based study of film reading with paper-
based data recording to investigate use of the forms, and contrasted
this with barcode data entry. Results reveal that the paper forms
provide an important communication tool, fostering collaboration
between readers. Specifically, they are used by readers: to indicate an
area of concern, and the nature of that concern, to a second reader or
arbitration meeting; to indicate to another reader that they have noted a
particular feature but decided that it is not of concern; for future
reference as a personal learning tool; and to express uncertainty and
seek reassurance from another reader. We conclude that barcode
systems should either support richer data entry or continue to be
supplemented with paper forms.
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Somerset Breast Screening serves a mainly rural population, with a
mobile unit visiting 22 sites throughout the county on a 3-yearly
screening cycle.
The age extension of the screening programme necessitated an
approximately 35% increase in the screening workload.
It was not possible to justify the expense of a second mobile unit as this
would only be required 1–2 days per week. Finding additional sites for
mobile units in small rural villages has become an increasing problem.
For these reasons it was decided to increase our capacity on the
existing mobile unit by using a shift system and extending the working
day. Initial staff consultation showed a willingness to explore this new
way of working.
A full screening day now extends from 8 am until 8 pm and utilises four
radiographers/assistant practitioner radiographers.
As a result of the extended day, Somerset Breast Screening has fully
implemented the age extension and is achieving a 36-month screening
round without the capital expenditure of a second mobile unit. Surveys
show a high level of popularity with our clients, especially for early
evening appointments, and high acceptance levels from our radio-
graphers and assistant practitioners.
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